STRUCTURAL CHARACTERIZATION OF THE EARLY STAGES OF THE BETA 2 MICROGLOBULIN AMYLOIDOSIS by M.M. Colombo
  
 
 
UNIVERSITÀ DEGLI STUDI DI MILANO 
Scuola di Dottorato in Scienze Biologiche e Molecolari 
XXIV Ciclo 
 
STRUCTURAL CHARACTERIZATION OF THE EARLY 
STAGES OF THE β-2 MICROGLOBULIN AMYLOIDOSIS 
  
 
 
Matteo Colombo (R08209) 
 
Coordinatore: Prof. Martino Bolognesi 
Tutor: Dott. Stefano Ricagno 
 
Anno Accademico 2010-2011 
ABSTRACT. 
Background. β-2 microglobulin (β2m) is an amyloidogenic protein responsible for 
dialysis related amyloidosis in man, which result in the deposition of β2m amyloid fibrils 
at a skeletal level. β2m is a 99 residue protein formed by two β-sheets linked by a 
disulphide bond. In the early stages of fibril formation, β2m associate into dimers and 
higher order oligomers that are structurally poorly characterized due to their transient 
nature. Furthermore, the aggregation properties of β2m are affected by its fold-stability. In 
particular, the DE loop region, which connect the D- and the E- strands, has been reported 
to be crucial for the β2m fold-stability.   
Results. Four monomeric β2m cysteine mutants (S20C, E50C, W60C and S88C) were 
produced and their correspondent disulphide-linked homodimers were prepared (DIMC20, 
DIMC50, DIMC60 and DIMC88). The aggregation properties, the crystallogenesis and the 
oligomerisation state in solution were tested for each β2m homodimer. DIMC20, DIMC50 
and DIMC88 form amyloid fibrils, crystals and display a varying mixtures of dimeric and 
tetrameric species in solution, while DIMC60 is not amyloidogenic and is purely dimeric 
in solution. DIMC20 and DIMC50 X-ray structures (2.45 Å and 2.7 Å resolution, 
respectively) shared a non-covalent D-D strand interface that mediate the formation of a 
tetrameric assembly in both DIMC20 and DIMC50. Moreover, DIMC20 and DIMC50 in 
solution can catalyse the w.t. β2m fibrils formation in the absence of fibril seeds at pH 7.4, 
strongly suggesting that the D-D strand interface is involved in the early stages of β2m 
amyloid aggregation.  
In order to further characterize the role of the DE loop in β2m fold-stability, a K58P-
W60G β2m mutant was produced and purified. The K58P-W60G β2m mutant showed 
improved thermal and chemical stability and a faster folding compared to the w.t. β2m. 
The crystal structure of the K58P-W60G β2m mutant (1.25 Å resolution) showed that the 
internal disulphide bond was severed as reported by Electrospray ionization-mass 
spectrometry spectra, which display that a fraction of the K58P-W60G β2m mutant has a 
reduced disulphide bond. These data suggest a stabilizing role of Pro58 and stress the 
importance of the DE loop on the biophysical properties of the β2m.     
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1 State of the art 
1. STATE OF THE ART 
1.1 A protein misfolding disease: β-2 microglobulin causes Dialysis 
Related Amyloidosis. 
Protein misfolding arises from the failure of proteins to fold correctly or to keep 
their native state. Protein misfolding can result in the extracellular or intracellular 
deposition of aggregates such as amyloid fibrils. The causes of protein misfolding 
can be genetic (e.g. Huntington’s disease), environmental (e.g. Alzheimer’s 
disease) or transmitted by infection (prion’s disease) 1. Although the pathogenesis 
of each protein misfolding disease is different, the formation of fibrillar 
aggregates is a hallmark of the amyloid related diseases. Amyloidosis can result 
from the conversion of a soluble folded protein into amyloid aggregates that in 
turn deposit extracellularly in a variety of organs such as heart, brain, kidneys and 
skeletal system. Amyloidosis can be divided in three major groups: 
neurodegenerative associated, localized non-neuropathic and systemic non-
neuropathic. Alzheimer’s and Parkinson’s diseases belong to the first group 
involving the extracellular accumulation of amyloid fibrils formed by Aβ1-40/ Aβ1-
42 peptides and α-synuclein respectively, which trigger the neuronal degeneration. 
Cataract is a localized non-neuropathic amyloidosis and it is caused by the 
aggregation of γ-crystalline in the retina. Dialysis related amyloidosis (DRA) 
pertains the third group and affects joints and tendons due to the accumulation of 
β-2 microglobulin (β2m) converted into amyloid fibrils (Fig. 1). β2m is a 99 
residue protein and it is recognized as a molecular archetype for the study of 
folding and amyloid transition processes. β2m tendency to aggregate is the focus 
of this thesis. 
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Figure 1. Schematic view of the Dialysis Related Amyloidosis etiology (see text) 
2
. 
 
β2m is the light chain of the class-I major histocompatibility complex (MHC-I) 3 
and stabilize MHC-I allowing its expression on the cell surface. β2m was first 
isolated by Berggard and Bearn from the urine of patients suffering tubular 
proteinuria 
4
. During the catabolic cycle of MHC-I, β2m dissociates and enters 
blood circulation as a monomer 
5
. Then, β2m is filtered by the glomerules in the 
kidneys and it is reabsorbed and destroyed  by proximal tubular cells 
6
. In patients 
with renal disorders and undergoing dialysis, β2m is not cleared and it starts to 
accumulate in the serum where its concentration increased up to 60-fold 
7,8
. Long-
term hemodialysed patients keeping the high concentration of β2m for 3-5 years 
start to accumulate amyloid fibrils in the synovium, cartilage and bones developing 
DRA. This pathology is characterized by carpal tunnel syndrome, bone cysts and 
chronic invalidating arthralgias resulting in bone fractures 
5
. Although many 
efforts, there are several features of the mechanism of the β2m amyloid fibrils 
formation that need to be depicted. Indeed, β2m maintains a monomeric state in 
solution up to milliMolar concentration and many factors such as metal ions, 
glycosaminoglycanes and proteases were suggested as β2m folding destabilization 
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promotors 
9,10
. Furthermore, very little is known about the early stages of the β2m 
aggregation and in particular the interactions that mediate the formation of the β2m 
oligomeric interfaces. In the next paragraphs I am going to summarize the main 
steps that lead to the formation of β2m amyloid fibrils: the amyloidogenic 
intermediate formation, the amyloidogenic regions of the β2m molecule and the 
data available on the structure of β2m amyloid fibrils.  
 
1.2 The relation between the β-2 microglobulin folding and an 
amyloidogenic intermediate. 
Protein folding is a spontaneous process and the funnel folding theory describes it 
as a progressive reduction of the free energy of the polypeptide chain from the 
unfolded state till the native state 
11,12
 (Fig. 2).  
 
Figure 2. A graphical representation of the funnel folding theory. A competition between 
intramolecular and intermolecular interactions during the protein folding 
13
. 
  
 
4 State of the art 
To reach the native state, unfolded β2m molecules have to cross a series of free-
energy barriers that correspond to partially folded species with a different degree of 
stability.   
In order to identify the β2m species that are on the folding pathway, kinetics 
studies were performed 
14-16
. In particular, the β2m folding process was studied by 
circular dichroism, double-jump experiments, intrinsic fluorescence and NMR 
14,16,17
. β2m folding revealed three different phases: a burst-phase, a fast phase and 
a slow phase 
15
. During the burst phase (sub-milliseconds time-scale) unfolded β2m 
molecules are converted into partially folded conformers (I1) with a significant 
level of secondary structure and a disordered hydrophobic core as revealed by far-
UV circular dichroism and ANS binding. The fast phase (millisecond time-scale) 
converts I1 into I2. This latter represents a population of partially folded conformers 
with a more compact hydrophobic core than I1 and a level of secondary structure 
similar to I1. I2 is then converted into the β2m native state through a slow-phase 
16
 
(Fig. 3).  
 
 
Figure 3. Schematic representation of the proposed β2m folding reactions. U, unfolded; I1, first 
intermediate; I2, second intermediate; N, native state 
15
. 
 
The slow phase of folding has been observed in vitro in many proteins such as 
Rnase A, Ribonuclease T1 and thioredoxin 
18-20
 and it has been related to the trans-
cis prolyl isomerization, which is an obligate step to achieve the final 
conformational state for many proteins 
21
. In the non-prolyl peptide bond the trans 
isomer is favored over the cis isomer by a factor of 100-1000 
22
. The case of 
proline is different because the nitrogen of the amide is bound to the δ-carbon of 
the prolyl side chain, forming an iminoacid. In the imine the trans and cis isomers 
  
 
5 State of the art 
are more equally distributed with a 30% of the cis isomers and a 70% of the trans 
isomers 
18
. This could be due to the comparable steric hindrance of the two proline 
isomers. β2m has five proline residues (Pro5, Pro14, Pro32, Pro72, Pro90), but 
Pro32 is unique in adopting a cis conformation in the native folded state. Kameda 
et al. 
16
 demonstrate that Pro32 trans→cis isomerization is responsible for the β2m 
slow-phase of folding by site-directed mutagenesis. In the P32V β2m mutant, the 
valine adopts a trans orientation, and its kinetic refolding monitored by both 
circular dichroism and 1D 
1
H NMR, showed the absence of the slow-phase due to 
the removal of the trans→cis isomerization. The prolyl-isomerization is also 
affected by the proline preceding residue. Indeed, NMR measurements of different 
peptides containing a histidine residue before a proline show a rate-isomerization 
dependence 
23,24
. In particular, the rate of prolyl-isomerization increased up to 10 
fold by changing the pH from basic to acid, when the proline preceding residue is a 
histidine 
23
. Moreover, at pH>7, histidine favors the increment of the cis proline 
isomer content suggesting an intramolecular mechanism that induce prolyl-
isomerization 
23
. The slow-phase of folding implies the presence of a β2m 
intermediate in which Pro32 displays a trans conformation, but the secondary 
structures and the hydrophobic core are well defined. It has been suggested that the 
trans orientation of Pro32 is a hallmark of the β2m aggregation prone species 16,25. 
Moreover, NMR experiments suggested that the trans orientation of Pro32 is 
accompanied by a general perturbation of the flanking residues and in particular of 
the FG loop and N-terminus 
16
. In addition, P32G β2m mutant, in which the glycine 
adopted a trans conformation, displays enhanced aggregation propensity compared 
to the w.t. β2m 26 and an increased amount of the amyloidogenic intermediate I2. 
Moreover, the level of I2 is correlated with the rate of the β2m fibril formation 
suggesting that the cis Pro32 isomer in the native state can be the limiting step of 
the β2m amyloid aggregation. 
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1.3 β-2 microglobulin amyloid fibril formation. 
A full understanding of the mechanism of the amyloid fibril formation requires the 
elucidation of every species that are on pathway. Interestingly, dependent from the 
ionic strength of the buffer, different amyloid fibrils can be obtained. Indeed, it has 
been shown that at pH 3.6 and at a concentration >100 mM NaCl, worm-like (WL) 
amyloid fibrils were obtained 
27,28
. Conversely, at pH 2.5 and at a concentration 
<100 mM NaCl, long-straight (LS) amyloid fibrils grew 
28
. Interestingly, LS 
amyloid fibrils grown at pH 2.5 and at pH 7.4 display a similar β-sheet architecture 
compared to the ex-vivo β2m amyloid fibrils 27. Recently, it has been shown that 
WL fibrils follow a non-nucleated mechanism for the fibrils formation, while LS 
amyloid fibrils are formed by a nucleation dependent mechanism 
29
; because LS 
fibrils were shown to be similar to the ex-vivo β2m amyloid fibrils, this thesis will 
be focused on the nucleation mechanism of the β2m amyloid fibril formation. β2m 
amyloid fibrils formed by a nucleation-dependent mechanism revealed a first-order 
kinetic reaction that is characterized by two main phases called lag phase and log 
phase. During the lag phase β2m molecules associate to form nuclei which in turn 
act as a scaffold for the elongation of the β2m amyloid fibrils by subsequently 
monomers or oligomers addition that lead to the formation of amyloid fibrils (log 
phase) (Fig. 4) 
1
. The lag phase can be overcome by adding seeds, which are 
fragments of sonicated mature amyloid fibrils. The lag phase is currently 
extensively studied, due to recent evidences that suggest that oligomeric species are 
the most toxic species in protein misfolding diseases such as Alzheimer and 
Parkinson 
1,30
. β2m oligomers are very difficult to isolate due to their rapid 
exchanging equilibrium. Recent data indicate that the first β2m oligomer formed is 
the dimer that in turn associate to form tetramers and higher order oligomers 
31
. 
Finally, cryo-electron microscopy on β2m amyloid fibrils grown at pH 2.5 revealed 
that a dimeric species of β2m can be the building block of the amyloid fibrils 32.  
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The final product of the β2m aggregation process are the amyloid fibrils. β2m ex-
vivo amyloid fibrils have been found associated with heparin and type I collagen 
33,34. Indeed, β2m amyloid fibrils are stabilized by glycosaminoglycanes such as 
heparin that has been shown to inhibit depolymerization of β2m fibrils in vitro 35. 
In order to mimic the environmental conditions that occur in vivo and that leads to 
the β2m amyloid fibrils, different approaches were used in vitro. Among different 
conditions the most used are the acidic pH (from pH 2.5 to pH 4.0) and the neutral 
pH with the addition of 20% TFE or stoichiometric amounts of Cu
2+
 
9,36,37
; the 
other in vitro conditions are listed in Table I. In general, the amyloid fibrils derived 
by different polypeptides display proteinase-resistance and measures ~10 nm 
diameter. Furthermore, amyloid fibrils bind Thioflavine T and they display a green 
birefringence, at the cross-polarized light microscopy, when they are bound to the 
Congo Red fluorescent dye 
38,39
.  
 
Figure 4. Phases of amyloidosis: lag phase, log phase and plateau phase. 
 
In the next paragraph will be summarized the unveiled structural features of the 
β2m amyloid fibrils. 
 
 
  
 
8 State of the art 
Table I. β2m amyloid fibril formation in vitro. 
Conditions for extension Seeds 
Acidic pH with varying ionic strength
28,40
 / 
Dialysis with pH 7.4 buffer containing 200 
μg mL-1 41 
/ 
Dialysis against deionised water and 
subsequent evaporation of solvent
42
 
/ 
pH 7.4, 150mM KCl, 1M urea with 200 μM 
Cu
2+9
 
/ 
Extension of seeds during refolding 
experiments
14
 
Ex-vivo β2m amyloid fibrils 
Extension of seeds in the presence of SDS 
0.5 mM, pH 7.5
43
 
Ex-vivo β2m amyloid fibrils 
Extension of seeds in the presence of TFE 
20%, pH 7.4
35
 
Ex-vivo β2m amyloid fibrils 
 
 
1.4 β2m amyloid fibril structure. 
The amyloid fibril structure derived by different polypeptides has been studied by 
X-ray diffraction revealing a common core structure with a cross-β architecture, 
where the β-sheets are oriented parallel to the long axis of the fibril and the β-
strand are perpendicular to the fibril long axis 
44
.  
To date, the high resolution structure of the β2m amyloid fibrils is not available. 
However, Hydrogen/deuterium exchange (H/D exchange) experiments performed 
on β2m fibrils grown at pH 2.5 revealed that the main regions protected in the β2m 
amyloid fibrils were the D-strand, the DE loop, the E-strand, the BC loop, the C-
strand and partially the B-strand 
45
. In agreement with Hoshino et al. 
45
, a recent 
SSNMR work reported that the structure of the β2m amyloid fibrils is built by 
native-like β2m monomers in which the major rearrangements occur in the loop 
regions such as AB loop (Ala15) and EF loop (Thr71 and Thr73) 
46
. 
Conversely, a parallel SSNMR study proposed that the structure of the β2m 
monomers that form the amyloid fibril are not native-like showing an increase in 
the β-structure content (a longer D-strand, a β-character for the native DE loop) 
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47,48
. Although the high resolution structure of the β2m amyloid fibrils represents 
the major challenge, there are evidences that the toxicity in amyloid diseases such 
as Alzheimer and Parkinson is mediated by oligomeric species more than amyloid 
filaments 
1
 underlying the importance of the structural characterization of the β2m 
oligomers. 
 
1.5 β-2 microglobulin native structure. 
β2m is the light chain of MHC-I and its physiological role is to drive the correct 
folding of the MHC-I for antigen presentation 
49
. β2m adopts an immunoglobulin-
like fold and is formed by two β-sheets linked by a disulphide bond. One β-sheet is 
formed by four β-strands (A, B, D, E) while the facing β-sheet has three β-strands 
(F, G, C). The disulphide bond link the two β-sheets by Cys25 (strand B) and 
Cys80 (strand F) (PDB 1LDS) (Fig. 5) 
50
. The disulphide bond is fundamental for 
the formation of amyloid fibrils; indeed, its reduction resulted in the abrogation of 
β2m amyloid fibrils formation 51. In the last decade, four main regions of β2m were 
indicated to affect the overall protein stability: the N-terminus, the D-strand, the 
DE loop and the BC loop (Fig. 5).  
 
1.5.1 The role of β2m N-terminus. 
The ex-vivo β2m amyloid fibrils are formed by 30% of ΔN6-β2m variant, which 
lack the first six residues 
52,53. ΔN6-β2m variant displayed a less compact fold with 
respect to the w.t. β2m 53. Moreover, circular dichroism experiments showed a 
decreased content of secondary structure and an altered tertiary structure of the 
ΔN6-β2m variant compared to the w.t. β2m 53. ΔN6-β2m variant resulted less 
stable compared to the w.t. in terms of chemical stability (Cm ΔN6= 1.65 M vs Cm 
w.t.= 2.23 M)  
53
. Importantly, ΔN6-β2m aggregates into amyloid fibrils at pH 7.0 
without the addition of seeds, which are commonly used to bypass the lag phase 
53,54
. Furthermore, a recently NMR structure of the ΔN6-β2m variant displays a 
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trans conformation of the Pro32 and it shows the property to convert the w.t. β2m 
into an amyloidogenic intermediate forming amyloid fibrils 
55
. 
 
 
Figure 5. A) Ribbon representation of the β2m fold. Residues Pro32, Trp60 highlight BC loop and 
DE loop, respectively. B) Primary sequence of β2m combined with its secondary structure. Circle 
represent residues that are located on loops, square represent residues forming β-structure (the 
scheme is taken from 
56
). 
 
ΔN6-β2m showed an increased propensity to oligomerize and in particular it has 
been suggested a ΔN6-β2m dimerization interface through the BC and DE loops 
based on the chemical shifts of residues 25-34 and 51-66 
55
.  
 
1.5.2  The role of the β2m DE loop and of the D-strand. 
The DE loop is formed by Ser57-Lys58-Asp59-Trp60 residues and it deeply affects 
the β2m folding stability and aggregation properties. The substitution of Trp60 
with a glycine resulted in an increased thermal and chemical stability of the β2m 57. 
Indeed, Trp60 is conserved among the vertebrates due to its interchain hydrogen-
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bonding with the Asp122 of the MHC-I 
58
. The increased stability of W60G β2m 
mutant was translated in the total abrogation of amyloid fibrils propensity at neutral 
pH in the presence of seeds 
57
. Conversely, the substitution of Asp59 with a proline 
decreases the thermal and chemical stability of the β2m which result in an 
enhanced tendency to aggregate 
59
. Moreover, ESI-MS experiments showed a 
lower propensity to establish protein-protein interactions of the W60G β2m 
compared to the w.t. β2m at neutral pH, under native conditions 60. All these data 
suggest that the DE loop geometry affects the folding stability of β2m and 
consequently its aggregation propensity 
59
. 
The DE loop is preceded by the D-strand, which has been repeatedly reported to be 
involved in the β2m fibrillogenesis 50,61,62. In this regard, NMR studies suggest that 
the D-strand adopts a number of conformations in solution and its flexibility could 
result as a favoring feature for the β2m aggregation. 
 
1.5.3 The role of the β2m BC loop and the copper binding. 
The BC loop contains the Pro32 residue, which is responsible for the slow-phase of 
β2m folding and that adopts a trans orientation in the β2m amyloidogenic 
intermediate. To date, the mechanism of the Pro32 cis-trans conversion is still 
unclear. However, His31 is a key residue in the Pro32 isomerization. Indeed, His31 
is the favorite copper binding site to β2m 16,36. A role of metal ions has been 
proposed for several amyloid diseases such as Parkinson, Alzheimer and prions 
63-
65
. In particular, Cu
2+
 often resulted the most effective metal ion in promoting 
amyloid fibrils formation; This feature may be due to the open shell system 
electron configuration of Cu
2+
 
66
. Regarding β2m, a mechanism for Pro32 
isomerization mediated by copper has been proposed 
62
. The copper binding can 
induce a protonation of the His31 imidazole nitrogen. The charged histidine 
determines a repulsion of the adjacent N-terminus, due to the positive charge on the 
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Arg3 side chain. The N-terminus is displaced and the Pro32 isomerization can 
occur. Interestingly, the same effect on the protonation of the His31 could be 
mediated by the acidic pH (pKa His31 = 5.4 
62
); indeed β2m forms fibrils at acidic 
pH faster compared to the neutral pH.  
 
1.6 β2m oligomers. 
Oligomeric β2m species are formed during the early steps of fibrillogenesis in the 
so-called lag phase. Due to their transient nature, their structural characterization is 
difficult. To date, β2m oligomers have been structurally characterized by ESI-MS 
and X-ray crystallography. The ESI-MS used a covalent labeling technique which 
allow to follow protein-protein interactions by measuring the differential reactivity 
of the amino acid side chains with specific compounds 
67
. This method was applied 
in vitro to β2m that was mixed with a fibrillogenesis buffer containing copper to 
study the dimeric and tetrameric species of the β2m 68,69. The side chains of the 
amino acids were covalently modified at different time points in order to identify 
the amino acids involved in intermolecular β2m interactions (dimer and tetramer 
formation). The degree of covalent labeling would be as low as the amino acids 
sensible to modification are involved in the dimer ad tetramer surfaces of 
interaction. The side chains sensible to covalent labeling are lysine and asparagine 
by acetylation (with NHSA), the side chains of histidine, serine and threonine that 
are carboethoxylated (by DEPC) and the side chains of arginine which are modified 
with butanedione (by BD) 
68
. Mendoza et al. 
68
 showed that the residues involved 
in the β2m dimer formation are located on the N-terminus, A-strand, AB loop and 
E strand, while D-strand, DE loop and G-strand mediate the tetrameric interface of 
the β2m (Fig.5A) 69. Recently, a new mass-spectrometry device was coupled to the 
ESI-MS, the ion mobility spectrometry (IMS), to study β2m oligomeric assemblies. 
IMS-MS has the capability of separating ions of the same m/z ratio but with 
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different collision cross-sections (Ω) and/or charge states by monitoring the 
mobility of an ion in a gaseous atmosphere under the influence of an electric field 
70
. Interestingly, ESI-IMS-MS on β2m oligomers produced under both low (on 
pathway for the worm-like fibrils) and high ionic strength (on pathway for the 
long-straight fibrils) at acidic pH, revealed β2m oligomers with different Ω which 
reflected a globular organization for the WL oligomers and an elongated 
conformation for the LS oligomers 
71
.  
Higher resolution data were obtained using X-ray crystallography. This technique 
needs high monodispersed samples in order to obtain protein crystals of good 
diffracting quality, and the nature of the oligomers seems to be in contrast. 
However, mutant design and protein engineering together with the use of 
antibodies or ligands (such as metal ions) can increase the stability of the 
oligomeric species allowing us to get insights in the early β2m protein-protein 
interactions. 
Indeed, the engineered P32A β2m mutant crystallized as a dimer  and its X-ray 
structure revealed a surface of interaction mediated by two straight antiparallel D-
strand (PDB 2F8O) 
25
 (Fig. 6A). However, P32A β2m mutant does not form 
dimeric species in solution and it is not amyloidogenic. 
Recently, the X-ray structure of the ΔN6-β2m variant was determined in complex 
with a specific camelide monoclonal antibody (PDB 2X89). Interestingly, the X-
ray structure displays a swapped dimer of the ΔN6-β2m variant, which is formed 
by two ΔN6-β2m monomers formed by six β-strands each (A, B, E, C, D, F) and 
with the G strand that is exchanged one to the other 
72
. 
The interactions between the monomers are mediated by residues 83-89 (F-strand) 
which formed a new β-sheet (Fig.6B). Interestingly, an isolated β2m peptide 
formed by residues 83-89 is amyloidogenic, suggesting that this region has an 
intrinsic propensity to aggregate 
74
.  
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Figure 6. Four β2m interfaces. A) Crystallographic dimer of the P32A β2m mutant. B) Swapped 
dimer of the ΔN6-β2m variant. C) D-D strand interface of the hexameric β2m of the H13F β2m 
mutant. D) Swapped dimer of the full-length β2m 25,61,72,73. 
 
Another recent X-ray structure of dimeric β2m based on domain-swapping was 
reported by Eisenberg and co-workers (PDB 3LOW) 
73
. In this case, the β2m 
swapped-dimer was isolated during the refolding step of β2m purification in the 
presence of BSH. The X-ray structure of the β2m domain-swapped dimer showed 
an open interface and a closed interface.  
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The former is mediated by an antiparallel β-sheet between the D strand and the E 
strand of the two β2m subunits. The latter is based on the rearrangement of the 
internal β2m disulfide that is mediated by Cys25 of one subunit and Cys80 of the 
facing subunit resulting in the formation of an intermolecular disulphide bond that 
in turn determined the exchange of the β-strand E, F and G between the two 
subunits.  
The H13F β2m mutant form a hexamer in solution in the presence of stoichiometric 
amounts of Cu
2+
 
61
. Moreover, the X-ray structure of the H13F β2m mutant 
revealed a hexamer which build two surfaces of interaction (PDB 3CIQ). One 
interface is mediated by the D strand, the BC loop and the E strand of two adjacent 
chains, while a second interface involves the stacking of the two ABED sheets of 
two adjacent β2m chains. The first interface is mainly mediated by His31, Asp34, 
His51, Phe56 and Trp60 and cover 700 Å
2
, while the second interface mainly 
involves stacking interaction between Tyr63, Tyr26 and Tyr10 of two adjacent 
chains 
61
 (Fig. 6C). Among the four oligomeric high resolution structures reported 
to date, the only amyloidogenic mutant is the swapped dimer ΔN6-β2m.  
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2. AIM OF THE THESIS 
β2m is an amyloidogenic protein that is responsible for dialysis related 
amyloidosis. One million people worldwide undergoing dialysis for 3-5 years are at 
risk of systemic amyloidosis due to β2m aggregation 75. The mechanism underlying 
β2m aggregation is not completely understood. Indeed, soluble β2m is converted 
into insoluble amyloid fibrils through a dynamic process that involves many 
transient species, from intermediates with a native-like conformation to dimeric, 
tetrameric and higher oligomeric species which in turn aggregate into amyloid 
fibrils. It has been recently reported that the oligomers, that are on pathway for the 
formation of the amyloid fibrils, are the most toxic species in protein misfolding 
disease (Alzheimer’s disease, Parkinson’s disease and prion’s disease) stressing the 
importance to provide structural insights in the early protein-protein interactions. 
Due to the low thermodynamic stability of these oligomers, it is very challenging to 
characterize their structural features to high resolution. Understand the interactions 
that occur at the early stages of β2m amyloidosis at a molecular level is 
fundamental to develop chemical compounds to treat DRA. This thesis is focused 
on two major points I) to isolate and characterize at atomic resolution β2m 
oligomeric species. II) to determine the β2m structural determinants that are 
correlated to the β2m aggregation propensity. The main approaches used are X-ray 
crystallography, fluorescence spectroscopy and circular dichroism.  
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3. MAIN RESULTS:  
3.1 A recurrent D-strand association interface is observed in 
β2m oligomers. 
 
3.1.1 β2m cysteine mutants design (S20C, E50C, W60C and 
S88C).  
 
In order to map the β2m protein-protein interactions that are important for the β2m 
fibrillogenesis, four β2m cysteine mutants were designed (S20C, E50C, W60C and 
S88C). The residues mutated are distributed on the overall structure of the β2m 
(Fig. 7). In particular Ser20 is located on the AB loop that adopt an inward 
conformation when β2m is bound to the MHC-I while it adopts an outward 
conformation when β2m is monomeric in solution 45,46,50. Glu50 and Trp60 lay on 
the N-termini and C-termini respectively, of the D-strand. This latter has been 
reported to be involved in the amyloid fibrils formation 
50,62
. Indeed, it has been 
hypothesized that a straight conformation of the D-strand would favor the 
aggregation of the β2m while the presence of a β-bulge at the residue 53 would 
impair the β2m cross-β arrangement 50. 
Residue 60 is very conserved among vertebrates because it is fundamental for the 
binding between β2m and MHC-I in the cell 58. Furthermore, Trp60 is located on 
the DE loop which has been recently shown to affect the stability of the β2m 59,76. 
Residue 88 lies on the FG loop. This region was previously indicated as the central 
β-spine of the amyloid fibril 74.       
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Figure 7. β2m cysteine mutants design. Sticks highlight the mutation sites. 
 
 
3.1.2 β2m disulphide-linked homodimers aggregation 
properties.  
The preparation of the disulphide-linked homodimers started by mixing each 
monomeric β2m cysteine mutant at a concentration of ~1660 μM with H2O2 at a 
molar ratio of 2:1 (see material and methods of manuscript I for details).  
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Figure 8. A) TEM Negative-stained amyloid fibrils of w.t., S20C/E50C/W60C/S88C β2m 
monomeric mutants and DIMC20/DIMC50/DIMC88 β2m mutants. B) ThT values for each β2m 
mutant at the plateau phase of fibrillogenesis. C) SEC profiles of each β2m homodimer. 1X 
indicates monomer, 2X dimer and 4X tetramer. D) SDS-PAGE of the fibrillogenesis samples of 
each β2m dimeric mutant dissolved into SDS 10%.  
 
The mix was loaded on a Superdex75 column in order to separate the various 
species based on their hydrodynamic radius. The elution profiles of each mix 
displayed the presence of the expected dimeric species (Fig. 8 C). The aggregation 
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properties of each homodimer were tested in solution and under amyloid 
conditions. By observing the elution profile of the preparative SEC, it is 
noteworthy that DIMC20, DIMC50 and DIMC88 showed an additional tetrameric 
species, referred to a single β2m molecule, while DIMC60 revealed only dimeric 
species. 
The dimeric species of the DIMC20, DIMC50 and DIMC60 were eluted at the 
same volume while DIMC88 is eluted later, revealing a more compact structure 
with respect to the other dimers. Furthermore, the amyloid propensity of each β2m 
homodimer were tested; indeed, DIMC20, DIMC50, DIMC60 and DIMC88 were 
mixed independently with the fibrillogenesis buffer (final concentration 100μM) 
and incubated at 37°C for 1 week. DIMC20, DIMC50 and DIMC88 showed 
positive values to ThT ( Fig. 8 B) and Congo Red binding. Furthermore, TEM 
images displayed the presence of amyloid fibrils (Fig. 8 A). Conversely, DIMC60 
does not bind ThT nor Congo Red and TEM images do not display any amyloid 
fibrils. Recently, Eisenberg et al.
73
 showed that β2m can form oligomers by a 
domain-swapped mechanism that involved a reorganization of the β2m internal 
disulphide bond showing a characteristic ladder of bands on the SDS-PAGE. In 
order to exclude a domain-swapped mechanism, the amyloid fibrils of DIMC20, 
DIMC50 and DIMC88 were dissolved in 10% SDS for 10 minutes and loaded on a 
SDS-PAGE (Fig. 8 D). The gel displayed that each of the amyloid fibrils sample 
showed a higher fraction for the dimeric species and only traces for the other 
oligomers, suggesting that the intermolecular-disulphide introduced does not react 
with the internal β2m disulphide bond and no domain-swapping occur in our 
samples. 
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3.1.3 Crystallogenesis of the β2m homodimers. 
In order to investigate the structure of the β2m homodimers, crystallization trials 
were performed using commercial crystal screens kits for each of the β2m 
homodimer. DIMC20, DIMC50 and DIMC88 protein crystals grew with different 
sizes and geometries, while DIMC60 failed to form protein crystals in any of the 
conditions screened. DIMC20 and DIMC50 crystals diffracted at a good resolution 
(2.45 Å and 2.7 Å, respectively) allowing to determine the protein structure, while 
DIMC88 crystals diffracted poorly (Fig. 9). 
 
 
Figure 9. Crystals of the DIMC20, DIMC50 and DIMC88 β2m mutants. 
 
3.1.4 DIMC20 X-ray crystal structure. 
DIMC20 was concentrated to 6 mg/ml in milli-Q water and protein crystals were 
grown by the sitting drop technique using Greiner 96-wells plates prepared by 
Oryx8 crystallization robot. DIMC20 was found to crystallize into Hepes 0.1 M pH 
7.7, CdSO4 0.12 M, sodium acetate 2.4 M, at T=293 K. Details of the DIMC20 X-
ray structure data reduction and refinement can be found in the manuscript I. In the 
unit cell of the crystal, the electron density revealed a tetrameric assembly, formed 
by a non-covalent interface between two DIMC20 molecules (Fig. 10 A). For the 
sake of the clarity, the terms tetrameric, dimeric and monomeric will be referred to 
a single β2m molecule. Each β2m monomer displayed a clear electron density for 
residues 0-99. Moreover, the (2Fo-Fc) map showed the presence of the 
intermolecular disulphide bond between the two engineered cysteine residues at 
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position 20 that form the DIMC20 molecule. Interestingly, the two DIMC20 
molecules that form the tetramer are not identical (r. m. s. d. 1.53 Å over 200 Cα 
pairs) and indeed display two somewhat different β2m chain conformations (r. m. 
s. d. 1.44 Å over 100 Cα pairs). Although they shared the same conformation of the 
AB loop, which adopts the inward orientation of the β2m in complex with MHC-I, 
they display a different conformation of the D-strand. Indeed, while one DIMC20 
molecule is formed by two β2m chains displaying a D-strand with a β-bulge at the 
residue 53 reflecting the same conformation of the D-strand of the β2m in complex 
with MHC-I, the second DIMC20 molecule β2m chains showed a D-strand in 
which the residues 52-55 adopt a less regular conformation. Nevertheless, all the 
β2m chains in the DIMC20 crystal structure matched β2m from the MHC-I 
complex (PDB 3I6G, r.m.s.d. 0.9 Å and 1.6 Å over 100 Cα for each β2m chain 
configuration). The quaternary structure revealed an antiparallel non-covalent 
interface (hereafter called D-D strand interface) of ~600 Å
2
 between the two 
DIMC20 molecules that is mediated by the D-strand, the DE loop, the BC loop, the 
E-strand and by a Cd
2+
 ion which was present in the crystallization buffer (Fig. 10 
C). In particular, His31 and Met0 of one chain and Asp34 of the adjacent chain 
coordinate a Cd
2+
 ion together with a water molecule, while Pro32 adopts a cis 
orientation. 
Besides, Trp60 of one chain is wedged in a hydrophobic pocket formed by Leu54, 
Leu64 and Tyr66 and formed stacking interaction with the aliphatic chain of 
Asp34. His51 of one chain established stacking interactions with Phe56 at one side 
giving rise to a hydrophobic pattern formed by residues Asp34, Trp60, Phe56 and 
His51. The region surrounding the intermolecular disulphide bond involves 
residues 12, 13 (A-strand), 18-22 (AB loop), 47 (CD loop), 52-54 (D-strand), 67-71 
(E-strand) and cover ~400 Å
2
. A residual electron density located among residues 
His13, Glu47, Glu69 was modeled as a Cd
2+
 ion. 
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Figure 10. A) Tetrameric assembly of DIMC20 formed by two disulphide-linked homodimers 
molecules (cyan and magenta). Grey spheres are cadmium ions. B) Tetrameric assembly of 
DIMC50 formed by two disulphide-linked homodimers molecules (cyan and gold). Magenta sticks 
represent phosphate ions. C) D-D strand interface of DIMC20. Dashed lines highlight hydrogen 
bonds and red sphere is a water molecule. D) D-D strand interface of DIMC50. Dashed lines 
highlight hydrogen bonds. 
 
 
3.1.5 DIMC50 X-ray crystal structure. 
DIMC50 was dissolved in milli-Q water at a final concentration of 9 mg/ml. The 
protein crystals were grown by sitting-drop technique in a Greiner 96 well plate 
prepared by Oryx8 crystallization robot. The optimum conditions of 
crystallogenesis resulted in imidazole-malate 0.2 M, pH 5.5, PEG 600 24% 
solution (Stura crystal screen MD1-20, condition 2) at T=293 K. The details of data 
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reduction and structure refinement are reported in the manuscript I. The DIMC50 
crystal diffracted at a resolution up to 2.7 Å. The asymmetric unit contains four 
molecules of DIMC50 assembled in two tight tetramers (one tetramer is shown in 
Fig. 10 B). For the sake of the clarity the terms tetrameric, dimeric and monomeric 
are always referring to a β2m chain. Residues 0-97 are clearly traced in the electron 
density calculated and all of the β2m chains are identical (r. m. s. d of 0.46 Å over 
98 Cα). Moreover, the four covalent dimers and the two tetramers are identical (r. 
m. s. d. of 0.78 Å over all the 196 Cα and a r. m. s. d of 0.62 Å over all the 392 Cα, 
respectively). Each β2m chain matches well the β2m in complex with MHC-I 
(PDB 3I6G, average over 98 Cα r. m. s. d 1.07 Å) displaying the same 
conformation of the AB loop and showing the β-bulge at the residue 53 on the D-
strand. The tetramer displays two non-covalent interfaces. One interface closely 
resemble the D-D strand interface observed in the DIMC20 X-ray structure and 
cover 570 Å
2
 (Fig. 10 D). Indeed, the D-D strand interface of DIMC50 involves a 
H-bond network established between Asp34 of one chain with the His31 of the 
adjacent chain. Moreover, Trp60 is inserted in a hydrophobic pocket formed by 
Leu54, Leu64 and Tyr66. Trp60 formed stacking interaction with the aliphatic side 
chain atoms of Asp34 of the adjacent chain as well as with Phe56 of the same chain 
that in turn establish stacking interaction with His51 of the opposite chain. Trp60, 
Asp34, His51 and Phe56 form a hydrophobic pattern that stabilize the interface as 
observed in the DIMC20 D-D strand interface.  
The second non-covalent interface is smaller and cover ~150 Å
2
. It is mediated by 
two chains that are disposed in an anti-parallel orientation and the main interactions 
occur between A and D strands. The interface contains a phosphate ion that is 
coordinated by Arg12 and His13 of one chain and by Lys58 of the opposite chain.  
The region surrounding the intermolecular disulphide bond includes residues 45-52 
of the CD loop and residues 67-69 located at the end of the E-strand. 
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3.1.6 DIMC20 and DIMC50 promote the w.t. β2m amyloid 
aggregation. 
Finally in order to shed light on the fibrillogenic properties of DIMC20 and 
DIMC50, unseeded fibrillogenesis tests have been performed using a mixture of 
DIMC20 or DIMC50 with w.t. β2m in a ratio of 1:3, respectively. As controls, in 
the same conditions unseeded reactions of w.t. β2m and of the mixture 
DIMC60/w.t. β2m (ratio 1:3) have been also carried out. As shown in Fig. 11A, 
DIMC20 and DIMC50 are able to trigger amyloid formation without seeds while 
the mixture of DIMC60/w.t. β2m and w.t. β2m alone do not aggregate (see Table 
I). In order to check that the amyloid fibrils of the DIMC20-w.t. and DIMC50-w.t. 
mixtures were formed by both the homodimers and w.t. β2m, the amyloid fibrils of 
each mixture were dissolved in SDS 10% and loaded on SDS-PAGE. The samples 
corresponding to DIMC20/DIMC50 together with the w.t β2m indicate that both 
species are aggregating. As controls, fibrils of w.t. β2m, DIMC20 and DIMC50 
alone were also analyzed by SDS-PAGE, displaying only one species, confirming 
that the two bands present in the mixed samples are indeed w.t. β2m and a 
disulphide-linked dimer (Fig. 11B).  
Taking all these data together, the DIMC20 and DIMC50 are highly amyloidogenic 
and can act as seeds for w.t. β2m. 
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Figure 11. A) Kinetics of the amyloid fibrils formation of the following unseeded reactions: w.t. 
β2m (■)  and the mixtures of DIMC20-w.t. 2m (1:3 ratio) (▼), DIMC50-w.t. 2m (1:3 ratio) (▲), 
DIMC60-w.t. 2m (1:3 ratio) (●). Bars represents standard deviations. B) SDS-PAGE showing  
soluble w.t. β2m (lane 1), then solubilised samples of DIMC20-w.t. amyloid fibrils (lane 2), 
DIMC50-w.t. amyloid fibrils (lane 3), amyloid fibrils of w.t. β2m (lane 4), amyloid fibrils of 
DIMC20 (lane 5), amyloid fibrils of DIMC50 (lane 6). 
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3.1.7 The D-D strand interface is involved in the early steps of 
the amyloidosis. 
DIMC20 and DIMC50 tetramers shared a common D-D strand interface, although 
their engineered disulphide bonds are located in two different regions in β2m 
structures. Interestingly, a modeling of the DIMC88 structure shows that the 
intermolecular disulphide bond would not impair the formation of a D-D strand 
interface. According to these considerations, DIMC20, DIMC50 and DIMC88 
display tetrameric species in solution and they are amyloidogenic, while DIMC60 
does not form tetrameric species in solution nor amyloid fibrils. Importantly, 
DIMC20 and DIMC50 resulted capable in promoting w.t. β2m amyloid 
aggregation in the absence of fibril seeds. This result implies that DIMC20 and 
DIMC50 share a compatible aggregation pathway with respect to the w.t. β2m. 
Recently, it has been reported that the ΔN6-β2m variant can catalyse the w.t. β2m 
amyloid aggregation in the absence of fibrils seeds 
55
. In the same article it has 
been reported that a D-D strand interface similar to the one reported in this thesis is 
observed at high concentration of the ΔN6-β2m variant. By observing the D-D 
strand interface, it is noteworthy that Trp60 is located in the middle of the interface, 
where it forms an hydrophobic pattern together with the aliphatic side chain of 
Asp34, Phe56 and His51; by inserting a disulphide at residue 60, the D-D strand 
interface would be impaired and the results here reported demonstrate that the three 
dimers (DIMC20, DIMC50 and DIMC88) that can form the D-D strand interface 
are amyloidogenic and oligomerize in solution, while DIMC60 failed. Moreover, 
DIMC60 does not induce a w.t. β2m amyloid aggregation. Another important 
feature emerging from the D-D strand interface is the involvement of residues 
His31 and Asp34. His31 is a key residue for the isomerization of the Pro32; indeed 
it has been proposed that His31 protonation triggers the cis-trans conversion of the 
Pro32 
62
.  
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Figure 12. A) Stereo-view of the superimposition among the D-D strand interfaces of H13F β2m 
(green), DIMC20 (magenta) and DIMC50 (light blue). For clarity, only the DIMC50 backbone is 
shown as ribbon (light blue). As a reference, three Glu16 residues are drawn as stick models. B) 
Stereo-view of the superimposition of the residues involved in the D-D strand interfaces shown in 
A). 
 
Interestingly, a hexameric structure of the H13F β2m mutant contained a D-D 
strand interface, involving the same residues (His31, Asp34, His51, Phe56, Trp60) 
and with a high degree of similarity (r. m. s. d. values of 3.3/2.0 Å calculated over 
the whole Cα backbones of dimers built across the D-D strand interfaces of 
DIMC20 and DIMC50, respectively) (Fig. 12). In the D-D strand interface of the 
DIMC20 a cadmium ion is coordinated by His31 of one chain and Asp34 of the 
facing subunit, with the Pro32 adopting a cis conformation. 
In the H13F β2m mutant hexameric structure, His31 participated to the 
coordination of a copper ion but the Pro32 adopted a trans conformation. The 
superimposition of the two metal binding sites shed light on the mechanism of the 
Pro32 isomerization mediated by metal ions (Fig. 13).  
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Figure 13. Stereo-view of the superimposition of the metal-binding site of DIMC20 (magenta) and 
H13F β2m mutant (green). Red sphere is water, green sphere is copper and magenta cadmium ion. 
 
Protonated His31 may be repulsed by Gln2 and Arg3 on the N-terminus that in turn 
is displaced. The N-terminus movement allows the Pro32 cis-trans isomerization 
and consequently the 180° rotation of Phe30 
62
 (Fig. 13). Moreover, NMR spectra 
of the amyloidogenic intermediate with Pro32 in a trans orientation showed that 
the regions adjacent to the BC loop, (DE loop and the N-terminus) are perturbed 
and poorly structured 
16
. Interestingly, these three regions are involved in the D-D 
strand interface, suggesting a cooperative role of the BC loop, the DE loop and the 
N-terminus in the β2m early steps of aggregation.    
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3.2 Unpublished Results 
3.2.1 β2m-cys mutants fibrillogenesis monitored by acrylodan 
fluorescence.  
In order to evaluate the role of the residues in position 20, 50, 60 and 88 and of the 
adjacent regions during fibrillogenesis, the four monomeric β2m-cys mutants were 
labeled with acrylodan 
77
. This latter is a fluorescent dye, which reacts specifically 
with cysteine residue. Acrylodan fluorescence varies the emission maximum 
(λMAX) upon change in solvent accessibility, allowing to follow local protein 
conformational changes. Each labeled β2m-cys mutants was mixed with the 
fibrillogenesis buffer and the amyloid fibrils formation was monitored by λMAX. 
Fluorescence spectra were recorded sequentially every 20 mins for each β2m-cys 
mutants. λMAX of each fluorescence spectra were plotted against time for each of 
the β2m-cys mutants (Fig. 14 E). The curves of the labeled S20C, E50C and S88C 
β2m-cys mutants were fitted with a single exponential equation y=y0+A*(e
R0t
) and 
data were summarized in Fig. 14 F, while the labeled W60C β2m mutant does not 
follow an exponential function. Moreover, labeled W60C does not form fibrils with 
the same amount of the other mutants. The degree of burial is indicated by the 
parameter A, which represents the slope of the curve. Results display that residue 
88 is more buried in the amyloid fibrils (AS88C= 23 nm) compared to the residues 
20 and 50 (AS20C= 19 nm and AE50C= 19 nm), that in turn showed a similar degree 
of burial.  
From the exponential equation y=y0+A*(e
R0t
) the rate constant R0 for each β2m-cys 
mutant was calculated (Fig. 15 F). Residue 88 displays a RS88C that is ≈ 2 times 
RS20C and RE50C. These values would suggest that the region around residue 88 is 
involved primarily in the fibrillogenesis process.  
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Figure 14. A-D) Initial and final fluorescence spectra (solid line and dotted line respectively) of the 
fibrillogenesis of each labeled β2m-cys mutant S20C (A), E50C (B), W60C (C), S88C (D). E) λMAX 
variation over time for each labeled β2m-cys mutant. F) Fitting data of the curves shown in E) with 
the exponential equation y=y0+A*(e
R0t
). W60C does not follow the exponential equation. 
 
 
3.2.2 Material and methods. 
Acrylodan labelling of the β2m Cys-mutants. 
Each monomeric β2m Cys-mutant and acrylodan were mixed in sodium phosphate 
10mM pH 7.4 in a 1:5 molar ratio and stirred O/N at room temperature. Samples 
were centrifuged at 10000 rpm for 8 mins, and the supernatant was collected. The 
degree of labeling has been calculated using the following equation: 
(AACRY/εACRY)*(MWβ2m-cys/mg/mlβ2m-cys) = molACRY/molβ2m-cys (provided by 
Invitrogen), where AACRY is the absorbance of acrylodan at λ=420 nm, εACRY= 
16400 M
-1
, MWβ2m-cys=11862 Da. Each cys-mutant yielded a good degree of 
labeling ranging from 50 M
-1
 to 90 M
-1
. The labeled β2m Cys-mutant was loaded 
on a Hitrap Desalting column in order to remove the acrylodan excess. 
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Fluorescence monitoring of labeled β2m Cys-mutants fibrillogenesis.  
Each labeled β2m Cys-mutant was mixed with Sodium phosphate 50 mM pH 7.4, 
TFE 20%, NaCl 0.1M and seeds wt β2m 2.5 μg/ml (hereafter referred as 
fibrillogenesis buffer) at a final concentration of 100 μM in a quartz cuvette, under 
shaking and incubated at 37 °C. Labeled β2m Cys-mutants fluorescent spectra were 
recorded every 20 minutes over ≈64 h using a Cary Eclipse fluorescent 
spectrophotometer (VARIAN). The excitation wavelength was set at 372 nm and 
the emission spectra were detected in the range 380-600 (nm). Acrylodan itself 
exhibits only a very low fluorescence quantum yield, while thiols adducts of 
acrylodan are brightly fluorescent and resulting in a fluorescence emission 
maximum (λMAX) of ≈530nm when it is completely exposed to polar solvents 
77
. 
Initial λMAX for all the four labeled β2m-Cys mutants is lower than expected for a 
completely exposed acrylodan. This is due to the presence of TFE in the 
fibrillogenesis buffer (controlled with β-mercaptoethanol, data not shown).  
The kinetic curves were calculated using the equation y=y0+A*(e
R0t
) by ORIGIN 
version 8.1. The estimation of the error is based on the standard error (SE) 
, where s is the standard deviation of the samples and n is the number of 
observations of each sample. 
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3.3 The effects of an ideal β-turn on the β2m fold. 
3.3.1  Design of the K58P-W60G β2m mutant. 
The second part of this thesis is focused on the structural determinants of β2m 
primarily related to its aggregation propensity. Recently, the geometrical strain of 
the DE loop has been reported to affect the overall stability of β2m. Indeed, the 
substitution of Trp60 with Gly confers a relaxed DE loop conformation which is 
translated with an increased thermal and chemical stability 
57
. Conversely, the 
substitution of Asp59 with Pro increases the strain of the DE loop that resulted in a 
diminished thermal and chemical stability of the β2m 59. Moreover, W60G and 
D59P display different aggregation properties; W60G does not form amyloid fibrils 
at neutral pH while D59P form amyloid fibrils faster than the w.t. β2m and a most 
abundant yield either at neutral pH and acidic pH. The K58P-W60G β2m mutant 
was designed to increase the β2m stability, because proline and glycine residues at 
positions 58 and 60 respectively, are considered the most favored residues to obtain 
a perfect type I β-turn (DE loop) that can further increase the β2m fold stability 78. 
3.3.2 Fold stability and folding kinetics. 
The conformational stability of the K58P-W60G β2m mutant has been assessed by 
means of chemical and thermal stability. Chemical stability was measured by 
guanidium hydrochloride equilibrium unfolding and it showed that the K58P-
W60G β2m mutant is more stable with respect to w.t. β2m (Cm K58P-W60G = 2.7 M 
GdHCl vs. Cm w.t.= 1.7 M GdHCl, while ΔG° K58P-W60G (H2O) = 7.6 kcal mol
-1
 vs ΔG° 
w.t. (H2O)= 5.5 kcal mol
-1
 ). Thermal stability was measured by circular dichroism 
(Far-UV and Near-UV) and by intrinsic fluorescence.  Near-UV and intrinsic 
fluorescence spectra revealed a higher stable tertiary structure of the K58P-W60G 
β2m mutant relative to the w.t. and comparable to that of the W60G β2m mutant. 
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Figure 15. Thermal stability assessed by circular dichroism in Near-UV (panel above) and Far-UV 
(bottom panel), for w.t. (red), K58P-W60G (blue), K58P-W60G reduced form (gray) and W60G 
(green). 
 
Moreover, Far-UV measurements show that the secondary structure of the K58P-
W60G β2m mutant unfolds at Tm= 73.5 °C against the Tm= 62.4 °C and Tm= 69.8 
°C of the w.t. and W60G β2m mutant respectively. Refolding kinetics was 
measured by intrinsic fluorescence and Far-UV circular dichroism. The intrinsic 
fluorescence revealed a rate constant of 1.6 s
-1
 for the w.t. and 10 s
-1
 for the K58P-
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W60G β2m mutant. Moreover, the K58P-W60G β2m mutant profile displays the 
absence of the slow phase of folding, which is detectable in the w.t. β2m. The 
refolding kinetics measurements based on the secondary structure (λ= 233 nm) 
show two similar profiles between the K58P-W60G β2m mutant and the w.t. β2m. 
Moreover, the slow-phase of folding was not detectable for both K58P-W60G β2m 
mutant and w.t. β2m.  
 
3.3.3 Crystal structure of the K58P-W60G β2m mutant. 
K58P-W60G β2m mutant was dissolved in milli-Q water at a final concentration of 
10 mg/ml and crystallized by hanging drop technique as described in the material 
and methods section of the Paper I. The X-ray structure of the K58P-W60G β2m 
mutant was determined to 1.25 Å resolution and the 100 amino acids were fitted in 
a very well-defined electron density. The mutated amino acids (Pro58 and Gly60) 
are clearly visible (Fig. 16 A).  
 
Figure 16. A) K58P-W60G structure showing the mutated residues (sticks). B) DE loop of the 
K58P-W60G showing hydrogen bonds (dashed line). C) Cys25 and Cys80 highlighted by electron 
density contoured at 1ζ, showing the absence of the internal disulphide bond. 
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The asymmetric unit contains one molecule of K58P-W60G β2m mutant and the 
DE loop displayed a type I β-turn conformation as observed in the crystal structures 
of the β2m mutants in which the Trp60 was replaced by cysteine, valine or glycine. 
However, the K58P-W60G β2m mutant DE loop is formed by the most favored 
amino acids for a type I β-turn (Ser57-Pro58-Asp59-Gly60) due to their 
stereochemical properties 
78
. Indeed, Ser57 (site i) is a polar residue that established 
a H-bond with the main chain nitrogen of the residue i+2; Pro58 is the ideal amino 
acid for the i+1 site, because of the restriction on the Φ angle to about -60°. At site 
i+3, glycine is the most favored residue because its flexibility allowed the 
completion of the β-turn and the beginning of the antiparallel E strand (Fig. 16 B). 
Moreover, the high resolution of the X-ray structure  allow to identify alternative 
conformations of the aromatic residues Phe56 and Phe62 together with two distinct 
D-strand arrangements. 
  
3.3.4 Reduced K58P-W60G β2m mutant. 
Combining the information provided by crystallography and ESI-MS (see the 
results section of the Paper I), it becomes evident that the K58P-W60G β2m mutant 
is present in solution as a mix of the common disulphide oxidized species with a 
disulphide-reduced variant of the K58P-W60G β2m mutant. In order to measure 
the fraction of the disulphide-reduced molecules, K58P-W60G β2m mutant was 
dissolved in 4M GdHCl and the level of free cysteine was assessed by titration with 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB). The results showed that the 30% of 
the cysteines were reduced confirming that the 30% of the K58P-W60G β2m 
mutant molecules display a severed disulphide-bond. Subsequently, the fold 
stability of the reduced form was assessed by circular dichroism thermal stability. 
The K58P-W60G β2m mutant was unfolded and completely reduced with 
  
 
37 Results: β2m fold stability 
dithiothreitol in the presence of GdHCl and then refolded (by removal of GdHCl) 
in the presence of dithiothreitol to prevent cysteine oxidation. The reduced K58P-
W60G mutant was successfully refolded according to Ohhashi et al.
79
. The thermal 
stability of the reduced variant of the K58P-W60G mutant could not be determined 
because the precipitation of the sample occur before the completion of the spectra. 
However, the onset of the transition occur 15-20 °C lower than the Tm of the other 
β2m mutants allowing us to hypothesize that the Tm should fall below 50-55°C. 
Intriguingly, a closer analysis of the thermal unfolding of the K58P-W60G mutant 
monitored by Trp-fluorescence revealed that the first derivative has a first, although 
minor, minimum at 48 °C. This may well represent unfolding of the reduced K58P-
W60G fraction (about 30%). On the other hand, the temperature ramps monitored 
by near- and far-UV CD detect only the unfolding of a major protein component 
(i.e. the disulphide-oxidised form), due to the lower sensibility (signal-to-noise 
ratio) of the CD signal compared to Trp-fluorescence. 
3.3.5 DE loop geometry affects the folding and the aggregation 
propensity of the β2m. 
The DE loop is a region of β2m that affects its aggregation propensity. Indeed, it 
has been reported to mediate protein-protein interactions in the H13F β2m mutant 
61
. Moreover, D59P and W60G β2m mutants represent the two edges of the DE 
loop effects on the overall β2m thermodynamical stability; while D59P confers 
rigidity to the DE loop resulting in an increased amyloidogenicity and in a lower 
thermodynamical stability compared to the w.t., W60G relaxes the geometry of the 
DE loop which resulted in the opposite effect observed for D59P mutant. The 
double mutant K58P-W60G was designed to transform the DE loop into a perfect 
β-turn according to the Hutchinson et al. 78. Data showed that the engineered β-turn 
increases the β2m thermodynamical stability compared to the w.t. insomuch as the 
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internal disulphide bond of β2m becomes not fundamental for the correct folding of 
the protein. Indeed, DTNB experiments assessed that nearly 30% of the purified 
K58P-W60G presented a reduced disulphide bond. These results reinforce the role 
of the DE loop in the β2m aggregation and the D-D strand interface previously 
reported strongly suggest an involvement of the DE loop in the early stages of β2m 
amyloidosis.
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4. CONCLUSIONS AND PERSPECTIVES: 
4.1 A recurrent D-strand association interface is observed in 
β2m oligomers. 
The experiments here presented highlight the role of a surface of interaction 
mediated by the D-strands of two β2m molecules in the early stages of    β2m 
amyloidosis. Indeed, DIMC20, DIMC50 and DIMC88 are amyloidogenic, while 
DIMC60 is not. In particular, DIMC20 and DIMC50 display a conserved D-D 
strand interface characterized at atomic resolution and moreover can trigger the w.t. 
β2m amyloid aggregation. Conversely, DIMC60, in which the D-D strand interface 
is impaired, resulted non-amyloidogenic and unable to catalyse the w.t. β2m 
amyloid formation. The residues involved in the D-D strand interface support a role 
for the BC loop and the DE loop for the early interactions. Given the biochemical 
and structural data, the D-D strand interface could be the target of drug design to 
impair the formation of β2m amyloid fibrils. Furthermore, DIMC88 X-ray structure 
could be important to determine if the D-D strand interface is conserved as 
suggested in the study here reported. Finally, β2m mutants affecting the residues 
involved in the D-D strand interface can be designed and their oligomerization 
properties characterized by ESI-MS and SEC in order to further investigate the role 
of the D-D strand interface. Moreover, the chemical shift investigation of the D-D 
strand interface residues in DIMC20 and DIMC50 could be monitored in a TFE 
buffer.  
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4.2 DE loop geometry affects the overall stability of β2m. 
The K58P-W60G β2m mutant was designed to further characterize the role of the 
DE loop on the β2m fold stability and aggregation properties. K58P-W60G β2m 
mutant resulted more stable compared to the w.t. β2m in terms of thermal and 
chemical stability. Moreover, K58P-W60G β2m mutant lacks the slow-phase of 
folding and can reach the correct shape although the internal disulphide bond is 
reduced. The crystal structure of the K58P-W60G β2m mutant shows that the DE 
loop forms a perfect β-turn. Finally, the K58P-W60G β2m mutant does not form 
amyloid fibrils at neutral pH strengthening the link between the folding stability of 
β2m and its tendency to form amyloid fibrils. In order to further evaluate the role 
of the DE loop in the β2m folding stability, it could be interesting to produce the 
K58P-W60G-P32A β2m mutant. Indeed, Ala32 would adopt a constitutively trans 
orientation which in theory may cause a destabilization of the β2m folding. 
However, it can also be hypothesize that the DE loop, in a perfect β-turn 
conformation can protect the β2m folding.         
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Summary.  
β-2 microglobulin (β2m) is an amyloidogenic protein responsible for dialysis 
related amyloidosis in man. In the early stages of amyloid fibril formation, β2m 
associates into dimers and higher oligomers, but the structural details of such 
aggregates are poorly understood. To characterize the protein-protein interactions 
supporting formation of oligomers, three individual β2m cysteine mutants and their 
disulphide-linked homodimers (DIMC20, DIMC50, DIMC60) were prepared. 
Amyloid propensity, oligomerization state in solution and crystallogenesis were 
tested for each β2m homodimer: DIMC20 and DIMC50 display a mixture of 
tetrameric and dimeric species in solution, yield protein crystals and amyloid 
fibrils, while DIMC60 is dimeric in solution, does not form protein crystals nor 
amyloid fibrils. The X-ray structures of DIMC20 and DIMC50 show dimers of 
(disulphide-linked) dimers, yielding a tetrameric assembly where an association 
interface based on the interaction of β2m D-strands is conserved. Notably, 
DIMC20 and DIMC50 trigger amyloid formation in w.t. β2m in unseeded 
reactions. Thus, when the D-D strand interface is impaired by an intermolecular 
disulphide bond (as in DIMC60), formation of tetramers is hindered, the protein is 
not amyloidogenic and does not promote amyloid aggregation of w.t. β2m. 
Implications for β2m oligomerization are discussed.  
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INTRODUCTION 
Amyloidosis is a generally pathological state in humans, characterized by the 
conversion of a correctly folded protein into insoluble highly organized fibrillar 
aggregates. It is at the roots of several protein misfolding diseases such as 
Alzheimer, Parkinson and Huntington diseases in man, and spongiform 
encephalopathy in cows 
80. β-2 microglobulin (β2m) is a 99-residue protein 
adopting an immunoglobulin-like fold, based on two facing β-sheets that are linked 
by a disulphide bond. β2m is the light chain of class I major histocompatibility 
complex (MHC-I) 
81. Under physiological conditions, β2m turnover takes place in 
the kidneys, where β2m is degraded. In case of renal failure, the degradation of 
β2m does not occur, and the protein accumulates in the blood increasing its 
concentration up to 50-fold, particularly in hemodialyzed patients 
8
. When a high 
β2m blood level is retained over the years, the protein self-associates into amyloid 
fibrils 
82
, which accumulate in the joints, bones and tendons, where amyloid fibrils 
aggregation is favoured by type I collagene and glycosaminoglycans (GAGs), 
determining Dialysis Related Amyloidosis (DRA) 
33
.  
β2m amyloid fibrils can be obtained in vitro using different approaches, such as 
the addition of metal cations like Cu
2+
 
9,36
, or by addition of denaturing agents or 
organic co-solvents at neutral pH 
35,37,43
. Among others, 2, 2, 2, trifluoethanol 
(TFE) is an organic solvent that promotes polar interactions between protein 
molecules favoring aggregation processes such as amyloidogenesis 
37
. Notably, 
β2m amyloid fibrils obtained in vitro display polymorphic nature, often linked to 
the different physicochemical fibrillogenic conditions employed 
83
. β2m conversion 
into mature amyloid fibrils requires the formation of partially folded species that 
aggregate into dimers, tetramers, higher order oligomers and eventually nuclei, 
which become the bases for fibril growth and elongation 
1
. Interestingly, it was 
recently reported that the ΔN6-β2m variant can catalyze the w.t. β2m amyloid 
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formation 
55
 revealing that folded w.t. β2m can be converted into a partially-folded 
amyloidogenic species by bimolecular collisions with the ΔN6-β2m variant. 
Several recent studies focused on the early stages of amyloid fibril formation in 
order to characterize the structure of the protein oligomers. In particular, a β2m 
dimer was proposed as the first pre-amyloid aggregated species formed during 
fibrillogenesis 
31,61,84
, and its structure was investigated through X-ray 
crystallography, electrospray ionization mass spectrometry (ESI-MS), cryo-electron 
microscopy and molecular dynamics simulations 
25,29,61,68,85
. The X-ray structure of 
the P32A β2m mutant crystallographic dimer showed a possible surface of 
interaction mediated by interactions of two antiparallel D-strands 
25
. More recently, 
the hexameric structure of the non-amyloidogenic H13F β2m mutant highlighted 
two possible dimer interfaces, one that involves the D-strands of two adjacent 
H13F β2m chains, and one that is mediated by stacking of the ABED β-sheet of 
two β2m molecules 61. A recent cryo-EM 3D-reconstruction of β2m amyloid fibrils 
grown at pH 2.5 stressed the hypothesis that the fibril unit blocks are built by 
globular tetramers, composed of dimers of dimers 
32
. Besides, ESI-MS analysis of 
w.t. β2m at neutral pH under non-denaturing conditions revealed the presence of 
dimers, trimers and tetramers 
60
. Interestingly, ESI-MS spectra of the W60G, 
W60V, D59P β2m mutants showed a decreased amount of oligomers, suggesting 
that the DE-loop (hit by the mutations) is involved in protein-protein interactions 
60
. More recently, a solid-state NMR study compared samples of native and fibrillar 
β2m 46, suggesting that the native β2m fold is mostly included in the fibrils, in 
keeping with previous evidences 
32,86. Thus, β2m would not undergo major fold 
rearrangements upon fibril formation, the main differences between the native and 
fibrillar β2m being located in loop regions 46.  
In the work here presented we produced three single-site β2m mutants where a 
Cys residue was individually engineered to replace Ser20, Glu50 and Trp60, 
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respectively. Covalent, disulphide-stabilized homodimers of each of the three 
single-site mutants were isolated, and their ability to form fibrils was investigated 
to assess whether the structural/topological constraints imposed by each engineered 
disulphide (differently located relative to β2m tertiary structure) would promote or 
inhibit fibrillogenesis. To shed light on the intermolecular interactions defining the 
assembly properties of the disulphide-linked homodimers, the X-ray structures of 
the E50C β2m mutant dimer (DIMC50) and of the S20C β2m mutant dimer 
(DIMC20) were determined. Our data may reconcile independent observations on 
other β2m oligomeric species, and in particular stress the role played by a specific 
interface for oligomer formation and amyloid aggregation. Such association 
interface is mediated by the interactions between the D strands of two adjacent β2m 
molecules and involves β2m residues previously identified as crucial for β2m 
amyloid aggregation. 
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RESULTS 
Design of β2m-Cys mutants.  
In order to explore the molecular mechanisms underlying formation of β2m 
amyloid fibrils, three β2m Cys-mutants (S20C, E50C, W60C) were produced and 
purified in a monomeric form. All the mutated residues are exposed to the solvent 
in the protein native fold 
50
; the three mutation sites were chosen in order to map 
very different regions of β2m. In particular Ser20 is located on the AB loop, a 
region protruding from the core of the protein that has been shown to adopt 
different conformations 
45,46,50
. Glu50 and Trp60 are located at the N- and C- 
termini of the D-strand, respectively; the D-strand is an edge strand that is involved 
in intermolecular interfaces in several crystal structures previously reported 
25,61
. 
Recent reports highlight a crucial role of the neighboring DE loop (residues 57-60) 
in β2m fibrillogenesis 57,59,60.  
 
Amyloid fibril formation of the monomeric species of β2m-Cys mutants.  
The ability of the three β2m Cys-mutants to aggregate as amyloid fibrils at pH 
7.4 in the presence of fibril seeds was assessed by ThT fluorescence, CR assay and 
TEM. Monomeric S20C and E50C β2m mutants display tendencies to form 
amyloid fibrils similar to w.t. β2m (Table I and Fig. 1B). On the other hand, W60C 
appears to be less prone to aggregation than w.t. β2m, in keeping with a previous 
report 
59. W.t. β2m and all the monomeric Cys-mutant species form amyloid fibrils 
with a diameter of ≈10 nm, morphologically similar as inspected by electron 
microscopy images (Fig 1A).  
 
Aggregation properties of the β2m (disulphide-linked) homodimers.  
Each of the three β2m Cys-mutants was used to produce the β2m disulphide-
linked homodimers (DIMC20, DIMC50, DIMC60) through the procedures 
  
 
54 Manuscript I, FEBS J. Under Review 
described in the Material and Methods section. For the sake of clarity, in the 
following the terms “monomer”, “dimer” and “tetramer” will always be relative to 
a single β2m chain, while DIMC20/50/60 will address the disulphide-linked 
homodimer formed by S20C/E50C/W60C mutants, respectively. Briefly, each 
monomeric β2m Cys-mutant was mixed with H2O2 in a molar ratio of 2:1 and 
incubated for 1h at room temperature. Each β2m mixture was then separated by 
size exclusion chromatography (SEC). The elution profiles of DIMC20 and 
DIMC50 showed varying relative abundance of dimeric and tetrameric species, 
while DIMC60 displayed only one peak corresponding to the dimer (Fig. 1C); the 
tetrameric species is particularly abundant in the DIMC20 elution profile. DIMC50 
is mainly eluted as dimeric species, with minor tetramer components. The mass of 
the main eluted species was assigned using static light scattering confirming the 
dimeric/tetrameric oligomerisation state (see Table S1 in Supplementary materials). 
To investigate the effects of the intermolecular disulphide bonds on β2m amyloid 
aggregation, fibrillogenesis tests for DIMC20, DIMC50 and DIMC60 were carried 
out using the same protocol used for the monomeric β2m Cys-mutants (pH 7.4, in 
the presence of 20% TFE and fibril seeds). DIMC20 and DIMC50 displayed a high 
ThT fluorescence signal after five days of incubation, higher than w.t. β2m and, 
moreover, displayed classical green birefringence after CR staining (see Table I, 
Fig. 1B and Fig. S3 in Supplementary materials). On the contrary, DIMC60 did not 
yield amyloid fibrils, showing a low ThT signal and a negative CR assay, even after 
months of incubation. In addition TEM images show the amyloid fibrils of 
DIMC20 and DIMC50 (Fig. 1A) while TEM images of DIMC60 samples do not 
reveal the presence of amyloid fibrils. 
 In order to assess that the intermolecular disulphide bond of each β2m mutant 
was indeed preserved in the aggregated materials, the amyloid fibrils of each 
homodimeric species were dissolved in 10% SDS and the samples examined 
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through SDS-PAGE. Under such conditions the amyloid fibrils of each β2m 
homodimeric mutant yielded a pure dimeric species, confirming the presence of the 
intermolecular disulphide in the β2m amyloid fibrils (see fig. S2 in Supplementary 
materials). Additionally, SDS-PAGE did not display any ladder pattern indicative 
of β2m oligomers of increasing size, contrary to what has recently been reported by 
Liu et al.
73
, who showed oligomers of various sizes (monomer, dimer, trimer, 
tetramer etc.) that resulted from a domain-swapping aggregation mechanism. 
 
Crystallization of the β2m homodimers.  
All β2m homodimers were screened for crystallization using commercial kits 
such as HCS I & II, STURA/MACROSOL and JENA 1-4 
87-89
. DIMC20 crystals 
grew in Hepes 0.1 M pH 7.7, CdSO4 0.12 M, sodium acetate 2.4 M, at T=293 K, 
using a sitting-drop vapor diffusion setup and diffracted up to 2.45 Å resolution. 
DIMC50 crystals were obtained in imidazole-malate 0.2 M, pH 5.5, PEG 600 24% 
solution at T= 293 K using a sitting-drop vapor diffusion setup and diffracted up to 
2.7 Å. In contrast, DIMC60 failed to form protein crystals under the same 
conditions screened for the other β2m homodimers. 
 
X-ray crystal structure of DIMC50.  
The structure of DIMC50 was refined at 2.7 Å resolution, with R-factor 23.4% 
and R-free 26.3% (see Table II). Each DIMC50 is formed by two chains of β2m 
E50C mutant linked by the expected disulphide bond between residues 50, as 
clearly shown by the electron density (see Fig. S1 in Supplementary materials). 
There are four DIMC50 moieties per asymmetric unit, assembled in two tight 
tetramers (Fig. 2A, showing only one tetramer). Each chain within a DIMC50 
moiety displays electron density of good quality for residues 0-97, and a high 
degree of structural similarity (r. m. s. d of 0.46 Å over 98 Cα atoms). Moreover, 
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the four DIMC50 moieties and the two tetrameric assemblies show a high level of 
similarity, with an average r. m. s. d. of 0.78 Å over all the 196 Cα (DIMC50), and 
a r. m. s. d of 0.62 Å over all the 392 Cα (tetramer), respectively. The β2m chains 
of the DIMC50 crystal structure most closely resemble β2m in its MHC-I complex 
(PDB 3I6G, average over 98 Cα r. m. s. d 1.07 Å), which displays the same 
conformation of the AB loop (residues 13-21) and of the DE loop (residues 57-60). 
Moreover, in the middle of the D-strand, residue 53 hosts a β-bulge, which has 
been previously observed in β2m complexed in MHC-I, but not in isolated β2m 
(PDB 1LDS 
50
). Finally, close inspection of the region around residue 50, and of 
the electron density in general, shows that neither the Cys mutation nor the 
formation of the covalent dimer modify globally or locally the β2m native fold, and 
no residue chemical modifications are present as a result of the H2O2 treatment. 
The two β2m chains linked in the same DIMC50 moiety, contact each other over 
an area of ≈ 270 Å2. Besides the S-S bond, the interface involves residues 45-52, 
which are located in the CD loop, and residues 67-69 that are located at the end of 
the E-strand. As mentioned above, two DIMC50 moieties tightly interact forming a 
tetramer of β2m chains. Two different non-covalent interaction surfaces in the 
tetramer cover 570 Å
2
 and 150 A
2
, respectively. The larger interface (hereafter 
called D-D strand interface) (Fig. 2B) is symmetric and involves the BC loop, the 
D-strand, the DE loop and the E-strand of the facing β2m chains (Table III). His31, 
Asp34, His51, Phe56 and Trp60 are the main residues involved in contacts at the 
association interface. In particular, His31 of one subunit establishes a hydrogen-
bond with Asp34 of the adjacent subunit (see Fig. 2B). Moreover, Trp60 and Phe56 
from one chain are located in an hydrophobic pocket built by Leu54, Leu64 and 
Tyr66, and are sandwiched between residues Asp34 and His51 of the adjacent 
subunit (Fig. 2B).  
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The smaller interface (hereafter called the phosphate interface) (Fig. 2C) is 
mediated by two β2m chains that are disposed in an anti-parallel orientation, where 
the main interactions are established by the A and the D strands. The interface hosts 
two phosphate ions located at its rims, held by the positive charges and H-bonds of 
Arg12 and His13 from one subunit, and by H-bonds from the backbone of Lys58 of 
the facing subunit, allowing stabilization of the tetramer (Fig. 2C). 
 
X-ray crystal structure of DIMC20.  
The structure of DIMC20 was refined at 2.45Å resolution with R-factor 22.6% 
and R-free 26.6 % (see Table II). Each DIMC20 is formed by two chains of the 
S20C β2m mutant linked by the expected disulphide bond (see Fig. S1 in 
Supplemetary materials). The asymmetric unit contains two DIMC20 moieties, 
yielding a tetrameric assembly of four β2m chains (Fig. 3A). Each DIMC20 
displays clear electron density for the intermolecular disulphide bond, and for 
residues 0-99. Contrary to what has been observed in the DIMC50 structure, the 
two DIMC20 units building the β2m tetramer are not identical (r. m. s. d. 1.53 Å 
over 200 Cα pairs), and indeed display two somewhat different β2m chain 
conformations (r. m. s. d. 1.44 Å over 100 Cα pairs). The main difference between 
such two conformations is located in the D-strand: in one DIMC20 moiety each 
β2m chain displays the same D-strand conformation observed in β2m MHC-I (Fig. 
3B, cyan), with a β-bulge at Asp53. In the other DIMC20 moiety, the D-strands 
(residues 51-56 in w.t. β2m) are interrupted by a less regular region between 
residues 52-55 (Fig. 3B, magenta). All the β2m chains in the DIMC20 crystal 
structure matched β2m from the MHC-I complex (PDB 3I6G, r.m.s.d. 0.9 Å and 
1.6 Å over 100 Cα for each β2m chain configuration). The four β2m chains do not 
display any modification in the regions close to the mutation site, nor the 
intermolecular disulphide appears to affect the overall β2m fold. Similarly to what 
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reported for DIMC50, no electron density features are present that would suggest 
additional residue oxidations due to H2O2 treatment. The two β2m chains within 
one DIMC20 unit display a surface of interaction of ~400Å
2
 that includes residues 
12, 13 (A-strand), 18-22 (AB loop), 47 (CD loop), 52-54 (D-strand), 67-71 (E-
strand). A residual electron density located among residues His13, Glu47, Glu69 
was modeled as a Cd
2+
 ion; indeed, CdSO4 was present in the crystallization buffer.  
Two DIMC20 moieties assemble into a tetramer, which embodies one non-covalent 
interface of 590 Å
2
. Such interface occurs between two β2m chains that display 
different conformations of the D-strand, resulting in an asymmetric contact 
interface. However, such association interface closely resembles the D-D strand 
interface observed in the DIMC50 structure (hence hereafter both are referred as D-
D strand interface) and it includes the BC loop, the D-strand, the DE loop and the 
E-strand (Table III). Notably, as observed for the DIMC50 D-D strand interface, 
His31, Asp34, His51, Phe56 and Trp60 are the residues providing the main 
association interactions. However, due to the two interface Cd
2+
 ions, the H-bond 
network between His31 and Asp34 is replaced by the coordination of a Cd
2+
 ion by 
His31 and Met0 of one subunit, and Asp34 of the neighboring subunit (Fig. 3C). 
The non-polar interactions observed in the D-D strand interface of the DIMC50 
structure are also partly modified in the DIMC20 tetramer. Firstly, two Asp34 
residues coordinate the Cd
2+
 ions; two Trp60 side chains are wedged in the same 
hydrophobic pocket built by Tyr66, Leu64 and Leu54, noted in DIMC50, however 
in the two chains the degree of insertion of residue Trp60 varies. Furthermore, in 
only one subunit Phe56 is stacked over Trp60 in the cavity, while in the other 
Phe56 is solvent exposed. Analogously, only one of the His51 side chains 
establishes intermolecular stacking interactions with Trp60 (as in DIMC50), while 
the second His51 residue is H-bonded to Lys58 of the neighboring molecule. 
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DIMC20 and DIMC50 promote w.t. β2m amyloid aggregation. 
   In order to shed light on the fibrillogenic properties of DIMC20 and DIMC50, 
unseeded fibrillogenesis tests were performed using solutions containing both 
DIMC20 (or DIMC50) and w.t. β2m, in a 1:3 ratio, respectively. As controls, 
unseeded reactions of w.t. β2m and of a DIMC60/w.t. β2m solution (1:3 ratio) were 
carried out under the same conditions. As shown in Fig. 5A, DIMC20 and DIMC50 
were able to trigger amyloid formation in the absence of fibril seeds (see Table I), 
while the mixture of DIMC60/w.t. β2m and w.t. β2m alone solution did not 
aggregate into fibrils.  
In order to check that the amyloid fibrils grown from the DIMC20/w.t. and 
DIMC50/w.t. solutions contained both the proper homodimer and w.t. β2m, the 
amyloid fibrils of each mixture were isolated, dissolved in 10% SDS and loaded on 
SDS-PAGE. In both cases, the samples were shown to contain both the disulphide-
linked homodimer and w.t. (Fig. 5B). Thus, DIMC20 and DIMC50, as soluble 
species and, notably, in the absence of fibril seeds, proved active in promoting β2m 
amyloid aggregation, leading to fibrils of mixed (homodimer/w.t.) composition. 
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DISCUSSION 
Three individual β2m cysteine mutants were designed, expressed and purified in 
a monomeric form. Each monomeric species was shown to aggregate into amyloid 
fibrils similarly to w.t. β2m, with the exception of the W60C β2m mutant that 
displayed lower propensity to aggregate, in agreement with previous published data 
59
. We then produced disulphide-linked homodimers for each of the β2m cysteine 
mutants. Engineering of the intermolecular disulphide bonds was undertaken as a 
means to restrain intermolecular contacts in a controlled way, allowing us to 
explore the mechanisms of β2m association through analysis of the mutant 
aggregation properties, under native and amyloidogenic conditions.  
The aggregation properties of the three homodimers were found to be remarkably 
distinct. The SEC elution profiles show that DIMC20 and DIMC50 behave as 
varying mixtures of dimeric and tetrameric species in solution, while DIMC60 is 
purely dimeric (Fig. 1C). Indeed, DIMC20 and DIMC50 crystal structures show 
that both homodimers assemble into tetramers in the crystals. Inspection of the 
crystal structures shows that despite the different locations of the intermolecular 
disulphide bonds in DIMC20 and DIMC50, their tetrameric species assemble 
through a largely conserved D-D strand interface (Figs. 2-3-4). In contrast, the 
formation of a disulphide bond at residue 60 would prevent tetrameric aggregation 
through the D-D strand interface; in agreement with such modeling considerations, 
DIMC60 does not assemble into higher species in solution. Related to these 
observations, DIMC20 and DIMC50 display similar amyloidogenic propensities, 
while DIMC60 amyloid formation appears totally hampered. Importantly, DIMC20 
and DIMC50 soluble species trigger w.t. β2m amyloid fibril formation at neutral 
pH, even in the absence of fibril seeds that are normally required to promote 
aggregation of the w.t. protein. Conversely, DIMC60 soluble species resulted 
inactive in promoting w.t. β2m amyloid formation. These observations suggest that 
  
 
61 Manuscript I, FEBS J. Under Review 
DIMC20 and DIMC50 have an aggregation mechanism compatible with the 
aggregation of the w.t. protein and that the D-D strand interface shared by DIMC20 
and DIMC50 can mediate the early steps of β2m amyloidogenesis. Interestingly, it 
has been reported that ΔN6-β2m (a naturally occurring β2m truncated version 
devoid of the first six residues) can catalyze w.t. β2m amyloid aggregation 55; based 
on NMR evidences, it has been suggested that the dimeric interface of the ΔN6-
β2m variant can be mediated by the BC loop and the DE loop 55. In this context, the 
same regions are involved in the D-D strand interface here presented. Furthermore, 
the X-ray structure of the ΔN6-β2m variant (PDB 2X89) in its complex with a 
nanobody was reported as a dimer based on domain swapping 
72
. The crystal 
asymmetric unit contains two ΔN6 β2m molecules that interact through a non-
covalent interface encompassing the BC loop, the D-strand and the DE loop (see 
Table III). Although the non-covalent interface displayed by the two ΔN6-β2m 
molecules does not match the D-D strand interface here reported, it is notable that 
the main residues involved in the interface (His31, Asp34, Phe56 and Trp60) match 
those observed in the dimer here described.  
The D-D strand interfaces observed in the crystal structures of DIMC20 and 
DIMC50 resemble closely the intermolecular association interface observed in the 
hexameric structure of the H13F β2m mutant (r. m. s. d. values of 3.3/2.0 Å 
calculated over the whole Cα backbones of the dimers built across the D-D strand 
interfaces of DIMC20 and DIMC50, respectively) (see Fig. 4A), which displays 
also a comparable contact area (DIMC20 and DIMC50 ~600 Å
2
 vs. H13F  mutant 
~700 Å
2
) 
61. Although some reorientation of the β2m molecules across the D-D 
strand interface is evident, it is striking that the main interactions at the D-D strand 
interfaces are closely conserved, and that the same quaternary assembly of two 
β2m chains is achieved. Thus, in keeping with all such observations, analysis of the 
data provided by our disulphide-linked dimers further suggests that the D-D strand 
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interface is a frequent association element for β2m molecules, compatible with 
maintenance of the protein native tertiary structure and with the formation of 
oligomers. Several previous reports have shown that the β2m amyloidogenic 
intermediate is native-like, and that such intermediate aggregates into early 
oligomeric species 
25,55,68,84
. Moreover, a dimeric assembly has been repeatedly 
suggested as the building block for the first steps of aggregation 
32,68
.  
Focusing on the D-D strand interface may help rationalize previous independent 
observations on residues His31, Asp34, His51, Phe56 and Trp60, held to be 
involved in β2m oligomer assembly. His31 was shown to be the primary binding 
site for Cu
2+
 
36, a process inducing formation of β2m amyloid fibrils in vitro and in 
vivo 
9
. However, since the H31Y mutant is poorly amyloidogenic regardless of the 
presence of Cu
2+
 ions, a more general function for His31 for β2m aggregation was 
suggested 
90
. Interestingly, the H31F mutant showed a residual affinity for Cu
2+
 
indicating the involvement of His31 neighboring residues 
36
; Asp34 is properly 
located to play such an auxiliary role in Cu
2+
 coordination and interestingly it is 
involved in the Cd
2+
 coordination in the DIMC20 D-D strand interface (Fig. 3). 
His51 is important for the stability of the D-D strand interface, being involved in 
stacking interactions with Phe56 (Figs. 2, 4) and in hydrogen bonding with Lys58 
in the DIMC20 structure (Table III). It has been shown that the H51F, H51Y and 
H51A mutants display a diminished tendency to oligomerize in the presence of 
Cu
2+
 
91
, suggesting that His51 may be involved in the formation of the early 
oligomers, and stressing the role played by this residue in the D-D strand interface 
here highlighted. Trp60 provides stacking interactions with Phe56 at the D-D 
strand interface and is located in the DE loop (residues 57-60), which was shown to 
play a prominent role in modulating amyloid aggregation propensity. Indeed, the 
substitution of Trp60 with Gly completely abolishes the amyloid propensity of β2m 
at pH 7.4 
57, while the W60V and W60C β2m mutants display decreased 
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amyloidogenic trends relative to w.t. β2m at pH 7.4 59,76. Trp60 is stabilized in the 
D-D strand interface by residues Leu54, Leu64 and Tyr66; accordingly, Platt et al. 
2008 
92
 showed the crucial role of the hydrophobic residues comprised in the 62-70 
stretch for the nucleation phase of β2m amyloid fibrils. 
For several amyloid related diseases, growing evidence indicates that protein 
oligomers of contained size are not only an obligate step towards the final 
deposition of amyloid fibrils, but may indeed represent the most cytotoxic species 
in the whole degenerative process 
1
. The characterization of such oligomers is 
technically challenging, due to their transient nature and to a persistent lack of high 
resolution structural models. Such structural information is however crucial in 
order to devise any therapeutic means or intervention able to antagonize 
oligomerization. By designing artificial disulphide-linked β2m dimers, we forced 
β2m molecules to display their preferred interaction modes in a simplified 
molecular model amenable to characterization through high resolution structural 
analyses. While previous β2m oligomers reported were not amyloidogenic 25,61, 
DIMC20 and DIMC50 are highly amyloidogenic and, most importantly, solutions 
of DIMC20 and DIMC50 can trigger, in the absence of fibril seeds, w.t. β2m 
amyloid formation. On the other hand, the lack of fibril formation by DIMC60, 
where association through the D-D strand interface is hampered, points to a role 
played by this interface in promoting β2m aggregation. The results reported above 
not only highlight a conserved pattern of β2m intermolecular contacts, but are in 
remarkably good agreement with β2m intermolecular aggregation models earlier 
reported 
29,84,93
. Under native or native-like conditions, β2m forms dimers that 
aggregate further into tetramers; β2m dimers have been suggested to be the 
building block of the mature fibrils 
32
; moreover, the final β2m fold hosted in the 
mature fibrils appears to be compatible with the native structure 
46
. In this context it 
is notable that the main residues building the D-D strand interface (His31, His51, 
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Phe56, Trp60, the C-terminal part of the D strand and the DE loop) have all been 
reported to be involved in intermolecular interactions stabilizing the mature fibrils 
47,48
.  
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MATERIALS AND METHODS 
 
Mutagenesis, expression and purification.  
β2m cysteine mutants (S20C, E50C, W60C) were produced using the 
QuikChangeTM site-directed mutagenesis kit supplied by Stratagene (La Jolla, 
CA) as previously described 
57
. The following primers were used: for S20C, 5’ 
CCA GCA GAG AAT GGA AAG TGT AAT TTC CTG AAT TGC TAT GTG 3’and 
3’ CAC ATA GCA ATT CAG GAA ATT ACA CTT TCC ATT CTC TGC TGG 5’. 
For E50C, 5’ GGA GAG AGA ATT GAA AAA GTG TGC CAT TCA GAC TTG 
TCT TTC AGC 3’ and 3’ GCT GAA AGA CAA GTC TGA ATG GCA CAC TTT 
TTC AAT TCT CTC TCC 5’. For W60C 5’ TTG TCT TTC AGC AAG GAC TGC 
TCT TTC TAT CTC TTG TAC 3’ and 3’ GTA CAA GAG ATA GAA AGA GCA 
GTC CTT GCT GAA AGA CAA 5’. The constructs were introduced in the BL21-
DE3 E. coli strain. A methionine residue, present at the N-terminal position of all 
recombinant products, will be referred to as Met0. Expression and purification of 
monomeric w.t. and β2m Cys-mutants species were carried out as previously 
reported 
53. The buffers used for β2m extraction from E.coli cells and the buffer 
used for Size Exclusion Chromatography (SEC) contained 1mM β-
mercaptoethanol to avoid the formation of intermolecular disulphide bridges. 
  
Fibrillogenesis of β2m Cys-mutants.  
Monomeric S20C, E50C, W60C and their isolated homodimeric species (DIMC20, 
DIMC50, DIMC60) were mixed with the fibrillogenesis buffer (sodium phosphate 
50 mM pH 7.4, TFE 20%, NaCl 0.1M, and w.t. β2m seeds 2.5 μg/ml) at a final 
protein concentration of 100 μM, and incubated quiescently at 37 °C as previously 
reported 
35
.  
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In the unseeded reactions, DIMC20, DIMC50 and DIMC60 were individually 
mixed with w.t. β2m in a ratio of 1:3 in an unseeded fibrillogenesis buffer at a final 
concentration of 100 μM and incubated quiescently at 37 °C. An unseeded w.t. β2m 
mixture was used as a negative control. The amount of amyloid fibrils for each 
sample was quantified by Thioflavine T (ThT) 
38
 and Congo Red birefringence 
assay (CR assay) 
39
. All the experiments were performed in triplicate. 
 
Transmission Electron Microscopy (TEM).  
Samples were diluted 1:20 in distilled water. 10μl were deposited on carbon-
coated grids and allowed to stand for 10 minutes before water excess was dried 
with filter paper. Then samples were negatively stained using uranyl acetate 2% 
solution for 2-3 minutes. The staining solution was removed using filter paper and 
the samples were analysed using an EFTEM LEO 912AB TEM. The same 
procedure was adopted for w.t. β2m, for the monomeric β2m Cys-mutants and for 
their homodimeric species. 
 
Production and purification of β2m Cys-homodimers (DIMC20, DIMC50 and 
DIMC60).  
Monomeric β2m-Cys mutant solutions (1.67 mM) and H2O2 were mixed in a 2:1 
molar ratio in sodium phosphate 0.25 M pH 8.0 at a final volume of 200 μl, and 
incubated 1h at room temperature. Each sample was loaded on a Superdex75 10/30 
column and eluted with sodium phosphate 50mM, pH 8.0. The molecular mass 
correspondent to each peak was determined using a multi-angle light scattering 
device (DAWN HELEOS, Wyatt), provided with a fast photon counter (QELS) and 
a differential refractometer (Optilab rEX). The determination of the molecular 
masses was performed by ASTRA V software (Wyatt Technology) using dn/dc = 
0.185 ml/g. The peaks corresponding to the tetrameric and dimeric species were 
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collected. β2m Cys-homodimers were desalted using Amicon centrifugal filter 
units (Millipore) cutoff 10 kDa, and lyophilized. 
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Crystallization and structure determination.  
   The lyophilized disulphide-linked dimer of the E50C β2m mutant (DIMC50) was 
dissolved in Milli-Q water at a final concentration of 9 mg/ml, and crystallized 
using an imidazole-malate 0.2 M, pH 5.5, PEG 600 24% solution (Stura crystal 
screen MD1-20, condition 2) at T=293 K, in a sitting-drop vapor diffusion setup. 
Crystals were flash-frozen using mother-liquor as cryoprotectant, and X-ray 
diffraction data were collected at the ID-14 4 beamline at 100 K, at the European 
Synchrotron Radiation Facility (ESRF, Grenoble). The lyophilized disulphide-
linked dimer of the S20C β2m mutant (DIMC20) was dissolved in Milli-Q water at 
a final concentration of 6 mg/ml, and was crystallized in Hepes 0.1 M pH 7.7, 
CdSO4 0.12 M, sodium acetate 2.4 M, at T=293 K, using a sitting-drop vapor 
diffusion setup. Crystals were flash-frozen at 100 K under paraffin oil, and X-ray 
data collection was performed at the ID-29 beamline at 100 K at the European 
Synchrotron Radiation Facility (ESRF, Grenoble). DIMC20 and DIMC50 crystals 
diffracted up to 2.45 Å and 2.70 Å, respectively. Diffraction data were then 
processed with MOSFLM 
94
 and SCALA 
95
 for DIMC50, while DIMC20 
diffraction data were processed using XDS 
96
 and SCALA 
95
. Phases were obtained 
through molecular replacement (PHASER 
97) using the W60G β2m mutant (PDB 
2Z9T) as search model for DIMC50, showing that eight chains of the E50C β2m 
mutant are hosted in the crystallographic asymmetric unit. Taking into account the 
intermolecular Cys50-Cys50’ disulphide, this arrangement corresponds to four 
DIMC50 covalent dimers per asymmetric unit. BALBES 
98
 was instead used to 
perform the molecular replacement for DIMC20, based on the PDB coordinates of 
the MHC-I β2m component (PDB  2X4S) as search model. In this case, two 
DIMC20 covalent dimers were located in the asymmetric unit. Both crystal 
structures were refined using REFMAC5 
99
; translation-libration-screw motion 
determination (TLSMD) 
100
 was applied in both cases. Non Crystallographic 
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Symmetry (NCS) was applied to improve the electron density for both DIMC20 
and DIMC50 
101
. Refinement of the metal ions was performed with autoBUSTER 
102
. Model building and structure analysis were performed using COOT 
103
. Data 
collection and refinement statistics are reported in table II.  
 
 
ACCESSION NUMBERS: 
Atomic coordinates and structure factors are available at the Protein Data Bank 
database under the accession codes 3TLR and 3TM6 for the structures of DIMC20 
and DIMC50, respectively. 
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Table I. CR assay for each β2m mutant.  
β-2m  variant CR assay scale: 
+++ > ++ > + 
w.t. +++ 
S20C ++ 
E50C ++ 
W60C + 
DIMC50 ++ 
DIMC20 +++ 
DIMC60 - 
DIMC20/w.t. ++ 
DIMC50/w.t. ++ 
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Table II. Data collection and refinement statistics for β2m DIMC20 and DIMC50 homodimers. 
Values in parenthesis are for the highest resolution shell. 
Structure DIMC20 DIMC50 
Beam line ID29 (ESRF) ID14-3 (ESRF) 
Space Group Orthorhombic 
P212121 
Monoclinic P21 
Unit Cell Constants 
(Å, º) 
a= 29.9 b= 98.2 
c=142.4  
a= 90.1 b= 56.3 
c=96.4 β= 115.7° 
Resolution (Å) 47.4-2.45 (2.58-
2.45) 
20-2.7 (2.85-
2.70) 
R mergea (%) 9.0 (53.2) 11.9 (41.8) 
I/ζI 8.4 (2.0) 5.6 (2.4) 
Completeness (%) 97.2 (98.9) 95.6 (97.4) 
Redundancy 3.1 (3.2) 2.8 (2.8) 
Unique Reflections 15721 (2285) 23049 (3416) 
R workb (%) 22.6 23.4 
R-freeb (%) 26.6 26.3 
Number of atoms: 3439 6729 
Protein 3347 6552 
Water 80 112 
Heteroatoms 12 65 
Ramachandran plot:   
Most favoured region 372 (94.9 %) 754 (97.8 %) 
Allowed region 15 (3.8%) 17 (2.2%) 
Outliers 5 (1.2 %) 0 
a R merge = hkl  Ihkl - < Ihkl >  / hkl  Ihkl  where I is the observed intensity and < I > is the average intensity. 
b R work = hklFo-Fc/hklFofor all data except 5% (DIMC20) and 10% (DIMC50) which were used for Rfree calculation. 
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Table III. Residues involved in the D-D strand intermolecular association interface of β2m dimeric 
species: DIMC20, DIMC50, H13F, ΔN6β2m.  
 DIMC20 DIMC50 H13F ΔN6-
swapped 
dimer 
N-ter Met0 (H) / / / 
BC 
loop 
His31(Cd), 
Asp34 (HCd) 
Ile35(W) 
His31(H), 
Asp34 (HW) 
His31(H), 
Asp34 (HW), 
Ile35 (H) 
His31 (W), 
Asp34 (W) 
D 
strand 
His51(HW), 
 
Leu54(W) 
 
Phe56 (W) 
His51(W) 
 
Leu54 (H), 
 
Phe56 (W) 
His51 (HW), 
Asp53 (H), 
Leu54 (H), 
Ser55 (H), 
Phe56 (HW) 
 
 
Leu54(W) 
 
Phe56 (W) 
 
DE 
loop 
Trp60 (W), 
Lys58 (HS) 
Trp60 (W) Trp60 (HW) Trp60 (W) 
E 
strand 
Phe62 (W), 
Leu64 (W), 
Tyr66 (W) 
Phe62 (W), 
Leu64 (W), 
Tyr66 (W) 
 
Leu64 (W), 
Tyr66 (W) 
/ 
W= van der Waals contacts, H= Hydrogen-bonding, Cd= cadmium coordination. 
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Figure legends: 
Figure 1. Aggregation of β2m Cys-mutants. A) TEM images of amyloid fibrils at 
pH 7.4 of w.t. β2m, S20C/E50C/W60C β2m monomeric mutants (left column), and 
of DIMC20/DIMC50 β2m homodimers (right column). DIMC60 does not yield 
amyloid fibrils. Scale bars represent 200 nm. B) ThT fluorescence intensity values 
(arbitrary units) measured at pH 7.4 on fibrils of w.t. β2m, S20C/E50C/W60C β2m 
monomeric mutants, and of DIMC20/DIMC50 β2m homodimers. DIMC60 does 
not yield amyloid fibrils. C) Size-exclusion chromatography profiles of w.t. β2m 
(dash-dot line), DIMC20 (dashed line), DIMC50 (dot line), and DIMC60 (solid 
line); labels on each peak indicate the estimated oligomerization state (4x, tetramer 
i.e. two interacting covalent dimers; 2x, a disulphide-linked dimer; 1x, monomer). 
Figure 2. Ribbons representations of the DIMC50 tetramer and its interfaces. A) 
The DIMC50 tetramer is composed of two DIMC50 moieties (cyan and gold, 
respectively). B) D-D strand interface highlighted by an orange circle. The side 
chains of Asp34, Trp60, Phe56, His51 are shown as stick models. Trp60 is inserted 
in the hydrophobic pocket built by Leu54, Leu64 and Tyr66. Asp34-His31 
hydrogen bonding is shown by a dashed line. C) Phosphate interface highlighted by 
an orange circle showing the hydrogen bonding scheme of one phosphate ion 
(magenta) with Lys58 backbone of the gold subunit, and with Arg12 and His13 of 
the cyan subunit. 
Figure 3. Ribbon representations of the DIMC20 tetramer and its D-D strand 
interface. (A) The tetramer is formed by two DIMC20 moieties highlighted in cyan 
and magenta, stabilized by cadmium ions shown as grey spheres. B) The D-D 
strand interface hosting two cadmium ions (grey spheres), and a water molecule 
(red). In C) the residues that coordinate the Cd
2+
 ions (grey) are represented as 
sticks. A network of hydrogen bonds linking His31and Met0 of one chain with 
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Asp34 of a facing subunit and one water molecule (red) surround the Cd
2+
 ion. 
Trp60 is inserted in the hydrophobic pocket built by Leu54, Leu64 and Tyr66, 
while Phe56 is partly exposed to the solvent. 
Figure 4. Superposition of D-D strand interfaces. A) Stereo view of the β2m 
dimers built across the D-D strand interface as observed in the crystal structures of 
DIMC20 (magenta), DIMC50 (light blue), and of the hexameric H13F mutant 
(green). For clarity, out of the three superimposed monomeric chains used for the 
comparison (lower part of the figure), only the DIMC50 backbone is shown as 
ribbon (light blue). As a reference, three Glu16 residues are drawn as stick models. 
B) Superposition of the residues involved in the D-D strand interface represented 
as stick (DIMC50 light blue, DIMC20 magenta, H13F β2m green).  
 
Figure 5. DIMC20 and DIMC50 triggers the w.t. 2m amyloid formation. A) 
Kinetics of the amyloid fibrils formation of the following unseeded reactions: w.t. 
β2m (■)  and the mixtures of DIMC20/w.t. 2m (1:3 ratio) (▼), DIMC50/w.t. 2m 
(1:3 ratio) (▲), DIMC60/w.t. 2m (1:3 ratio) (●). Bars represent standard 
deviations. B) SDS-PAGE showing  soluble w.t. β2m (lane 1), then solubilised 
samples of amyloid fibrils of the DIMC20-w.t. 2m mixture (lane 2), amyloid 
fibrils of the DIMC50-w.t. 2m (lane 3), amyloid fibrils of w.t. β2m (lane 4), 
amyloid fibrils of DIMC20 (lane 5), amyloid fibrils of DIMC50 (lane 6). 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Table S1. Mass values of the eluted SEC species determined by static light scattering. 
Oligomeric 
species 
DIMC20 
molecular mass 
(Da) 
DIMC50 molecular 
mass (Da) 
DIMC60 molecular 
mass (Da) 
2X (dimer) / 30190±150 24290±95 
4X (tetramer) 47760±140  / / 
 
Molecular masses corresponding to the main elution peaks reported in Fig. 1C, 
assigned by Static Light Scattering (SLS). The dimeric species and tetrameric 
species of the DIMC20 and DIMC50, respectively, although visible from the SEC 
elution profiles were not measured by SLS because their amount was below the 
level of detection. The mass of the DIMC50 was slightly overestimated likely due 
to a minor tetrameric component coeluted with the dimeric species. DIMC60 is 
purely dimeric and display a mass value correspondent to a dimeric form of β2m. 
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Fig. S1 
 
 
Fig. S1. Disulphide bonds are in yellow. A) Front-view of the disulphide-linked 
homodimer of the DIMC20 formed by two β2m chains (magenta and blue). B) 
Side-view (90° rotation considering the parallel axis of the intermolecular 
disulphide bond) of the two β2m chains forming DIMC20. C) Front-View of the 
disulphide-linked homodimer of the DIMC50 formed by two β2m chains (violet 
and cyan). D) Side-View (90° rotation considering the parallel axis of the 
intermolecular disulphide bond) of the two β2m chains forming DIMC50. It is 
notable the different position of the engineered intermolecular disulphide between 
DIMC20 and DIMC50. 
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Fig. S2 
 
Fig. S2. SDS-PAGE of the SDS-dissolved amyloid fibrils of the w.t. β2m, DIMC20 
and DIMC50 grown at pH 7.4, TFE 20% in the presence of w.t. β2m fibril seeds. 
Amyloid fibrils of the w.t. β2m, DIMC20 and DIMC50 were centrifugated at 
10000 rpm for 10 min. The supernatant was discarded and 10% SDS was added to 
the amyloid fibrils. Each sample was incubated for 10 min at room temperature and 
loaded on a SDS-PAGE. The gel showed that the intermolecular disulphide of both 
DIMC20 and DIMC50 was not impaired during the amyloid fibril formation. 
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Fig. S3 
 
Fig. S3. Amyloid fibrils of w.t. β2m/S20C/E50C/W60C/S88C and of the 
DIMC20/DIMC50 display the typical amyloid green-red birefringence when 
stained by Congo Red.  
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to be prone to aggregation similarly to N6 b2m (9).
Furthermore, an important role has been assessed
for the b2m Pro32 residue that shows a cis-peptide
bond in wild-type (wt) b2m. In the P32A b2m
mutant, the amide group of Ala32, has a trans con-
formation, determining a total abrogation of the lag
phase observed for the formation of amyloid ﬁbrils in
the wt protein (10). It has also been reported that,
under acidic conditions, substitution of the aromatic
residues in the 6270 sequence stretch with Ala, results
in a decreased ﬁbril elongation rate and an increased
ﬁbrillogenesis lag time (11), suggesting that this hydro-
phobic region is important for the ﬁbril nucleation
mechanism.
The aggregation properties of wt and mutant b2m
have also been investigated by electrospray ioniza-
tionmass spectrometry (ESIMS) and ion mobility.
Three species of b2m have been identiﬁed (native, par-
tially unfolded and acid unfolded), whose distribution
depends on pH and mutations (1215). Recently, the
b2m loop between the D and E strands, which com-
prises residues 5760, has been shown to be critical for
b2m amyloid propensity (16). In particular, Trp60 is a
strongly conserved residue among vertebrates due to
its crucial role in the association of b2m with the heavy
chain in the MHC-I complex (16). The substitution of
the conserved residue Trp60 with Gly totally abrogates
the amyloidogenic process under mild conditions, and
results in an increased fold stability compared to
wt b2m (16, 17). The W60G mutant shows a distinct
behaviour also under denaturing conditions, where it
shows kinetics of disulphide reduction slower than
wt b2m. The crystal structure of the W60G mutant
shows that all residues of the DE loop fall in the fa-
voured regions of the Ramachandran plot, suggesting
that the mutation to Gly confers higher overall stabil-
ity to b2m, thanks to its unique conformational prop-
erties that help release stereochemical strain of the DE
loop (16). Conversely, the mutation of Asp59 to Pro
leads to a more strained DE loop, resulting in dimin-
ished thermal stability and increased propensity to
form amyloid ﬁbrils compared to wt b2m (18).
Comparative analysis of the DE loop conformations
shows that wt b2m and the D59P mutant display an
irregular DE loop, while the W60G, W60V and W60C
mutants host a regular b-turn (19). All such data sug-
gest that increased stability of the DE loop may trans-
late into b2m variants of increased overall stability.
In this respect, we notice that the W60G mutant
lacks a Pro residue in position 58 to reach the most
favourite residue distribution for a type I b-turn in the
DE loop (20).
Here, we report on the double substitution of b2m
residues Lys58 with Pro and Trp60 with Gly. Our aim
was to produce a b2m variant endowed with the most
stable type I b-turn in the DE loop, and to analyse the
effects of the double mutation on b2m overall proper-
ties. To this purpose, the isolated K58P-W60G mutant
has been characterized by means of ﬂuorescence, cir-
cular dichroism (CD), crystallography and mass spec-
trometry analyses. Furthermore, the K58P-W60G
mutant amyloidogenic propensity was assessed at low
and neutral pH values. The results here reported show
that regularization of the protein conformation in
the DE loop leads to stabilization of the whole b2m
structure.
Materials and Methods
Mutagenesis, expression and purification
Mutagenesis of Lys58 to Pro was performed using the
QuickChangeTM site-directed mutagenesis kit (Stratagene, La
Jolla, CA, USA) starting from the plasmid of the W60G mutant
(16). The following primers were used: for K58P, 50-TCA GAC
TTG TCT TTC AGC CCG GAC GGG TCT TTC TAT CTC
TTG-30 and 30-CAA GAG ATA GAA AGA CCC GTC CGG
GCT GAA AGA CAA GTC TGA-50. The construct was introduced
in the BL21-DE3 Escherichia coli strain. A methionine residue, pre-
sent at the N-terminal position of all recombinant products, will be
referred to as Met0. Expression and puriﬁcation of wt and b2m
K58P-W60G species were carried out as previously reported (8).
Thermal and chemical unfolding
In all the temperature ramps here described, b2m was in 50mM sodium
phosphate pH 7.4. The protein concentration was 1.4mg/ml (cell path
1 cm) or 0.1mg/ml (cell path 0.1 cm) for measurements in the near-
and far-UV regions, respectively. The temperature increment was set
to 50C/h (0.83C/min). b2m temperature unfolding from 20C to
95C has been simultaneously followed by intrinsic Trp ﬂuorescence
and by near-UV CD signals on a Jasco J-810 spectropolarimeter,
equipped with a Peltier device and ﬂuorescence detector. Wavelength
was set at 293 nm to follow simultaneously the variation of molar
ellipticity and to excite tryptophan. Emitted ﬂuorescence was de-
tected at 350 nm. The Trp-ﬂuorescence of b2m variants bearing or
not Trp60 is comparable since, as previously shown, the Trp60 ﬂuor-
escence is almost totally quenched by the solvent (21). Temperature
unfolding of b2m secondary structure has been monitored by far-UV
CD at 202 nm.
Stopped-flow refolding
Kinetics of tertiary structure refolding was monitored by Trp-
ﬂuorescence for wt b2 microglobulin (b2m) and W60G b2m using
a Bio-Logic SFM-300 stopped-ﬂow ﬂuorimeter, with an excitation
wavelength of 295 nm and monitoring the total ﬂuorescence emission
change at 320 nm. All the experiments were performed at 303K in
10mM sodium phosphate buffer, pH 7.4, at 0.02mg/ml ﬁnal protein
concentration. The refolding experiments were performed by a
10-fold dilution of unfolded protein samples (0.2mg/ml in 4M
GdHCl).
Kinetics of the secondary structure recovery was studied by
stopped-ﬂow CD using a BioLogic SFM-20 stopped-ﬂow system
ﬁtted to a Jasco J-810 spectropolarimeter. The protein (20 ml of
0.2mg/ml in 4M GdHCl) was mixed with 480ml of buffer (sodium
phosphate 50mM pH 7.4) in 100ms (dead time 10.8ms). Data traces
were recorded at 233 nm through a 2-mm cell path and ﬁtted using a
ﬁrst-order rate equation by means of SigmaPlot 2001 software.
Crystallization and structure determination
The K58P-W60G b2m mutant was crystallized using the hanging-
drop vapour diffusion technique under the following conditions:
protein solution at a concentration of 10mg/ml, sodium acetate
0.1M pH 5.5, ammonium acetate 0.2M, PEG4000 22%, glycerol
20%. Crystals of the mutant protein grew in few days at 20C.
X-ray diffraction data were collected on ﬂash-frozen crystals
using the crystallization mother-liquor as cryoprotectant, at 100K,
at the beamline ID1-4 1 (the European Synchrotron Radiation
Facility, ESRF, Grenoble, France). The K58P-W60G crystals dif-
fracted to 1.25 A˚ resolution. Diffraction data were processed with
MOSFLM (22) and SCALA (23). Phases were obtained by molecu-
lar replacement using MOLREP (24) and the W60G b2m mutant
atomic coordinates (PDB code 2VB5) as search model. The reﬁne-
ment process was performed with REFMAC5, riding hydrogen
atoms and anisotropic B factors have been applied at the end
of the reﬁnement (25). Model building, structure analysis and
Kleywegt plot were carried out using COOT (26) (see Table II).
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ESIMS
A hybrid quadrupole-time-of-ﬂight instrument (QSTAR Elite,
Applied Biosystems, Foster City, CA, USA) was employed for
ESIMS analysis, using a nanospray source and metal-coated boro-
silicate capillaries with medium-length emitter tip of 1-mm internal
diameter (Proxeon, Odense, Denmark). The following instrumental
settings were applied: declustering potential 80V; ion spray voltage
1.11.2 kV; curtain gas 20 PSI. Samples were sprayed at room tem-
perature. Samples were prepared as equimolar mixtures of wt b2m
and K58P-W60G mutant (5mM each) in 10mM ammonium acetate
(Sigma Aldrich, St Louis, MO, USA), adjusting the pH to 7.4 or 2.5
with ammonium hydroxide (Sigma Aldrich, St Louis, MO, USA) or
formic acid (Merck KGaA, Darmstadt, Germany), respectively.
Amyloid fibril formation at pH 7.4 and 2.5
b2m (100 mM) was incubated at 37C in 50mM phosphate
buffer,100mM NaCl, pH 7.4, in the presence of 20% (v/v) TFE
(7). b2m ﬁbril seeds (20 mg/ml) were added to the samples. To
form amyloid ﬁbrils at acidic pH, b2m (100 mM) was incubated at
37C in 50mM Nacitrate and 100mM NaCl, pH 2.5, in the pres-
ence of 20 mg/ml of b2m ﬁbril seeds (27). Quantiﬁcation of amyloid
formation was performed with ThT according to Ref. (28). ThT
(SIGMA) concentration was 10 mM in 50mM glycineNaOH
buffer, pH 8.5. A VARIAN Cary Eclipse spectroﬂuorimeter was
used for the measurements, with excitation at 445 nm and emission
collected at 480 nm, with slits set at 5 nm and high voltage. The
measurements are the average of three independent experiments.
Results
Fold stability and folding kinetics
K58P-W60G b2m mutant conformational stability,
determined by guanidium-hydrochloride equilibrium
unfolding, shows an increased chemical stability
with respect to wt b2m (melting concentration,
Cm K58P-W60G¼ 2.7M GdHCl versus Cm wt¼ 1.7M
GdHCl), while G(H2O) is 7.6 kcalmol
1 for the
K58P-W60G mutant and 5.5 kcalmol1 for wt b2m;
b2m chemical unfolding has been followed by Trp
ﬂuorescence (Fig. 1A). Furthermore, in order to obtain
an independent assessment of the K58P-W60G b2m
stability, thermal unfolding was monitored by CD
(near- and far UV) (Fig. 1B) and by intrinsic ﬂuores-
cence. Near-UV CD and Trp-ﬂuorescence approaches
show that the K58P-W60G b2m mutant displays
distinctly higher tertiary structure stability relative to
wt b2m, comparable to that achieved by the W60G
mutant (Table I). Interestingly, far-UV CD analysis
reveals that the K58P-W60G mutant has a melting
temperature, Tm¼ 73.5C, thus a thermal stability
higher than both the W60G mutant and the wt protein
(TmW60G¼ 69.8C and Tm wt¼ 62.4C) (17) (Table I).
Refolding kinetics were monitored by intrinsic ﬂuor-
escence (Fig. 2A and B). In the K58P-W60G mutant,
the rate constant of the folding fast phase shifts from
1.6 s1 for wt b2m to 10 s1 for the mutant. The plat-
eau is reached after 5 s for the mutant (versus 20min
required for wt b2m). Therefore, the slow phase of
folding, observed for wt b2m, is not detectable in the
double mutant, similarly to what has been previously
reported for the W60G mutant (16).
In order to compare the folding process of wt b2m
and the K58P-W60G b2m mutant based on secondary
structure, refolding kinetics were monitored by CD at
¼ 233 nm. As shown in Fig. 2C, the proﬁles for the
two b2m variants are indistinguishable. It is note-
worthy that the slow phase, which is observed in wt
b2m folding by Trp-ﬂuorescence, is absent in both wt
and mutant b2m when refolding is monitored by
far-UV CD.
Crystal structure of K58P-W60G b2mmutant
The crystal structure of the K58P-W60G b2m mutant
was solved and reﬁned at 1.25 A˚ resolution, with Rwork
of 14.4% and Rfree of 17.2% (Fig. 3A and Table II).
All the 100 amino acids are clearly traced in the elec-
tron density, which is of excellent quality, clearly deﬁn-
ing the mutated Pro58 and Gly60 residues. As for the
other b2m mutants affecting residue 60 (16, 18, 19) in
the K58P-W60G mutant the DE loop matches the
Fig. 1 Thermal and chemical fold stability of the K58P-W60G b2m
mutant. (A) Unfolding titration curves as a function of denaturant
(GdHCl) concentration for wt b2m, W60G and K58P-W60G
mutants. The fraction of unfolded protein is reported on the y-axis.
(B and C) Temperature dependence of circular dichroism signal, in
near-UV (B) and far-UV (C) for w.t. b2m (red), K58P-W60G
mutant (blue), reduced K58P-W60G (grey) and W60G mutant
(green).
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canonical conformation of a type-I b turn. According
to Hutchinson et al., speciﬁc residues are preferred for
each of the four positions of a type-I b turn, due to
their stereochemical properties. At the b turn site i (cor-
responding to residue 57 in the K58P-W60G structure;
Fig. 3B) a polar residue (typically Asp, Ser, Cys and His),
which can establish a H-bond with the main chain
nitrogen of the iþ 2 residue, is preferred. At site
iþ 1, a Pro residue is favoured because of the restric-
tion on the  angle to about 60. At site iþ 2 Asp,
Arg, Ser and Thr are preferred. Finally, at site iþ 3
Gly is the most favoured residue, since it helps the
polypeptide chain return to an anti-parallel b-structure
after completion of the turn (20). The K58P-W60G
mutant, with its amino acid sequence 57-SPDG-60,
thus displays the most favoured residues at each of
the four sites. Moreover, residues Ser57 and Asp59,
together with Ser61 (the ﬁrst residue after the b
turn), help stabilizing an overall compact structure in
the 5761 sequence stretch (Fig. 3B).
Relative to the other b2m mutants of known 3D
structure, K58P-W60G shows a higher degree of alter-
native residue conformations. In particular, thanks the
high resolution achieved, alternative conformations
were observed for the aromatic residue cluster of
Phe56 and Phe62. Moreover, the polypeptide back-
bone in the D strand was found in two similar but dis-
tinct conformations. Notably, the very high-resolution
structure (1.13 A˚) of wt b2m does not display any of
such alternative conformations (29).
Unexpectedly, the disulphide bond between Cys25
and Cys80, which usually locks the two b2m
b-sheets, was found severed in the crystal structure of
the K58P-W60G mutant. To our knowledge, this is the
ﬁrst b2m structure where such a reduced disulphide
bond is observed. Cys80 shows extra side chain density
indicative of an oxidized species; the extra density was
modelled as a sulphenic acid (i.e. OH group bound
to the thiol group; Fig. 3C). On the other side of the
severed disulphide, Cys25 side chain is observed in
three alternative conformations. The structures ob-
tained from several crystals, grown from different puri-
ﬁcation batches, all show the same pattern of
reduction. Given the known effects that X-rays may
exert on proteins [reviewed in (30)], rupture of the
disulphide bond can be (partly of fully) linked to the
X-ray diffraction experiments run on a high-intensity
synchrotron source. Nevertheless, the behaviour ob-
served here, unprecedented for b2m, suggests that
the disulphide bond in the K58P-W60G mutant is
more labile to radiation damage than in wt and in
the other previously described DE b2m mutants.
However, radiation damage may be not the only factor,
since several lines of evidence suggest that part of
the protein is already reduced before crystallization
(see below).
Unfolding and reductionmonitored by ESIMS
Figure 4 shows the nano-ESIMS spectrum of an
equimolar mixture of K58P-W60G mutant and wt
b2m under non-denaturing conditions. The signals of
the two proteins are clearly distinguishable due to their
different masses. Both proteins are folded, as indicated
by the narrow charge-state distribution (CSD) showing
only the 8þ and 7þ ions. Mass deconvolution yields the
values of 11,860 0.5Da for the wt protein, and
11,700 0.5Da for the mutant, in excellent agreement
with the calculated mass for the proteins containing an
oxidized disulphide (11,860.28 and 11,700.06Da,
respectively). By lowering the pH (Fig. 4B), the CSDs
are shifted towards higher z-values, consistent with
acid-induced protein denaturation taking place under
such conditions. However, the main charge state of the
wt protein is 11þ, while that of the mutant is 13þ,
indicating more extensive unfolding in the latter.
Interestingly, mass deconvolution performed only on
the high-charge peaks of the mutant yields the mass of
the disulphide-reduced protein (11,702.06 0.5Da).
These data indicate that part of the mutant protein is
already in the reduced state in the absence of reducing
agents. Such component is masked by the oxidized
protein under mild ESI conditions, since both oxidized
and reduced proteins populate the same charge states.
However, it becomes detectable at low pH because
protein unfolding can proceed more extensively in
the reduced protein, leading to higher charge states
than the unfolded protein with an intact disulphide.
Thus, the highest charge state is dramatically enriched
in the contribution of the reduced component and the
2-Da mass shift can be detected. No evidence of
oxygen addition (i.e. formation of a sulphenic centre
at Cys80) is found in the ESIMS data, suggesting that
the modiﬁcation observed in the crystal structure is
merely an artefact due to X-ray radiation damage.
Reduced K58P-W60G b2mmutant
Combining the information provided by crystallog-
raphy and ESIMS, we propose that in solution the
K58P-W60G mutant may coexist as two species: the
common disulphide-oxidized form and a reduced vari-
ant where the disulphide bond between Cys25 and
Cys80 is absent. In order to verify such hypothesis,
the K58P-W60G mutant protein was unfolded in 4M
GdHCl and the level of free cysteine was assessed by
Table I. Summary of chemical and thermal unfolding results for b2m variants.
Cm (GdHCl)
"G (H2O)
kcal mol1
Tm (Near-UV)
(C)
Tm (Trp-ﬂuorescence)
(C)
Tm (Far-UV)
(C)
wt b2ma 1.7M 5.5 63.8 64.1 62.4
W60G mutanta 2.5M 6.6 71.6 71.7 69.8
K58P-W60G mutant 2.7M 7.6 69.9 73.0 73.5
aMelting temperatures taken from Santambrogio et al. (17).
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titration with 5,50-dithiobis-(2-nitrobenzoic acid)
(DTNB). The titration conﬁrmed that 30% of the
cysteines are in the reduced state (data not shown),
indicating that in 30% of the b2m molecules present
in solution the disulphide bond is severed.
Subsequently, the ability of the reduced K58P-W60G
mutant to fold to a wt-native structure was assessed.
The mutant protein was unfolded and completely
reduced by dithiothreitol (DTT) in the presence of
GdHCl, and then refolded (by removal of GdHCl) in
Fig. 3 Crystal structure of the K58P-W60G b2m mutant.
(A) Cartoon representation of the crystal structure of the
K58P-W60G mutant. Strands are labelled according to the conven-
tion for b2m. Residues Cys25, Cys80 and the mutated Pro58
and Gly60 are shown as stick models. (B) Stick model of the
K58P-W60G mutant DE loop. Residues are labelled according to
Hutchinson et al. type I b-turn deﬁnition. H-bonds are shown by
dotted lines; the H-bond linking Ser57 OG (i) and the peptidic N of
Asp59 (iþ 2) is weak (3.43 A˚) and has not been drawn. In addition to
those shown in the ﬁgure, H-bonds (3.0 A˚) stabilizing the b-turn
region are observed between: the peptidic N atom of Ser57 and the
carbonyl O of Ser61 (iþ 4), Ser57 OG atom and the peptidic N of
Ser61, the carboxylate of Asp59 and Ser61 OG. (C) The 2FOFC
electron density map of the severed disulphide bond in K58P-W60G,
contoured at 1.0 s, highlights the triple conformation of Cys25 and
the oxidized Cys80 sulphenic centre (both represented as stick models).
Fig. 2 Refolding kinetics of the K58P-W60G b2m mutant.
(A and B) Intrinsic ﬂuorescence curves of wt b2m (black) and of the
K58P-W60G mutant (grey), monitoring the fast-phase and the
slow-phase of folding. (C) CD far-UV folding curves of wt b2m
(black) and of the K58P-W60G mutant (grey).
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the presence of DTT to prevent cysteine oxidation. The
reduced K58P-W60G mutant was successfully refolded
according to Ohhashi et al. (31) and the thermal sta-
bility of the reduced protein was monitored by CD
(Fig. 1B). These observations are in keeping with pre-
vious results on the role of the disulphide bonds in
immunoglobulin fold stability (32). A proper unfolding
Tm could not be directly measured, since the reduced
K58P-W60G mutant shows a distinct propensity to
precipitate before the end of the transition (also at the
low concentration used in the far-UV region). However,
the onset of transition occurs at least 1520C
lower than observed for the other mutants (Fig. 1B),
allowing us to hypothesize that the Tm should fall
below 5055C.
Intriguingly, a closer analysis of the thermal unfold-
ing of the K58P-W60G mutant monitored by
Trp-ﬂuorescence revealed that the ﬁrst derivative has a
ﬁrst, although minor, minimum at 48C (Supplementary
Fig. S1). This may well represent unfolding of the
reduced K58P-W60G fraction (30%). On the other
hand, the temperature ramps monitored by near- and
far-UV CD detect only the unfolding of a major protein
component (i.e. the disulphide-oxidized form), due to the
lower sensibility (signal-to-noise ratio) of the CD signal
compared with Trp-ﬂuorescence.
Amyloid fibril formation
The K58P-W60G mutant propensity to form amyloid
ﬁbrils was analysed either at pH 7.4 in the presence of
20% TFE, or at pH 2.5, in both cases with small-
controlled additions of wt b2m ﬁbril seeds. Under
both conditions, a wt b2m control ﬁbrillogenesis was
performed. The data at pH 7.4 show that, after 1 week
of incubation at 37C, wt b2m forms amyloid ﬁbrils,
bind thioﬂavin T (ThT) and is positive to Congo Red
(CR) staining, while the K58P-W60G mutant does not
bind ThT (Fig. 5) and displays a negative CR assay
(data not shown). On the contrary, at pH 2.5, both wt
b2m and the K58P-W60G mutant are prone to aggre-
gation, as shown by ThT and CR assays, with a higher
ﬁbril yield for the K58P-W60G mutant relative to wt
b2m. Such distinct behaviour is similar to what has
been observed for the W60G b2m mutant (16).
Discussion
Recent studies have focused the attention on the cru-
cial role(s) played by Pro residues on b2m fold and
stability. The Pro5 to Gly mutation results in the
accumulation of an amyloidogenic intermediate with
Fig. 4 Fold stability of reduced and oxidized K58P-W60G b2m mutant monitored by ESI-MS. Nano-ESIMS spectra of an equimolar (5 mM)
mixture of wt b2m (black) and K58P-W60G mutant (red) in 10mM ammonium acetate, pH 7.4 (A) or pH 2.5 (B). The instrument interface was
set at room temperature. The most intense charge state of each component is labelled by the corresponding charge state. Peaks in the dashed
boxes correspond to the fully reduced mutant protein (11 702 Da).
Table II. Data collection and reﬁnement statistics for b2m
K58P-W60G.
Beam line ESRF ID14-1
Space group Monoclinic C2
Unit cell constants (A˚, ) a¼ 76.35, b¼ 28.58,
c¼ 60.73, b¼ 132.9
Resolution (A˚) 19.01.25 (1.321.25)
Rmerge
a (%) 10.0 (69.2)
I/I 15.5 (3.2)
Completeness (%) 99.6 (97.2)
Redundancy 10 (8.7)
Unique reﬂections 26776 (3812)
Reﬁnement
Rwork
b (%) 14.4
Rfree (%) 17.2
Number of atoms
Protein (Avg. B-factor, A2) 935 (10.0)
Water (Avg. B-factor, A2) 132 (21.0)
Ramachandran plot
Most favoured region 99 (99%)
Allowed region 1 (1%)
Values in parentheses are for the highest resolution shell.
aRmerge¼|I5I4|/|I| where, I is the observed intensity and5I4
is the average intensity.
bRwork¼hkl||Fo| |Fc||/hkl|Fo| for all data except 5% which were
used for Rfree calculation.
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lower structural compactness than observed for the
native protein, causing a higher propensity to aggre-
gate for the P5G mutant than for wt b2m (9).
Mutations of Pro32 also lead to b2m variants with
non-native fold and with different amyloidogenic
properties compared with the wt protein (10, 33, 34).
Both Pro5 and Pro32 are located in loops, where they
likely help holding the entire protein in the compact
native fold. On the other hand, we have recently pre-
pared a b2m DE loop mutant introducing a Pro resi-
due in position 59 (18). The presence of a proline in the
DE loop does not affect the overall protein fold,
however it increases the loop geometrical strain, low-
ering b2m fold stability and markedly enhancing its
amyloidogenic propensity (17, 18). These three ex-
amples show how ‘native Pro’ residues are carefully
located in order to increase the stability of loops,
and, in general, of the b-sandwich structure, while
not adding strain to b2m backbone geometry.
In a recent work, the Trp60 to Gly mutation was
shown to give rise to a regular b-turn conformation
in the DE loop region (16). The work reported here
introduced the Lys58 to Pro mutation (in addition to
the Trp60 to Gly mutation) in order to mimic the effect
of a ‘native Pro’ residue, e.g. to serve as a ‘lock’ of a
loop, and to stabilize the overall protein conformation
by building an ideal type-I b-turn. Complementary
biophysical and structural techniques have been used
to characterize the double mutant. As a ﬁrst result, we
conﬁrm that the DE loop indeed adopts the ideal type I
b-turn conformation (Fig. 3B), with Pro58 occupy-
ing position iþ 1 of the turn. Thermal and chemical
unfolding indicates that the K58P-W60G mutant has
a distinctly higher conformational stability than wt
b2m (Fig. 1). Folding experiments show that the
K58P-W60G mutant folds faster than the wt protein,
and that the folding slow phase is absent (Fig. 2).
Additionally, the double mutation leads to a vari-
ant that does not form amyloid under the standard
conditions at pH 7.4 with 20% TFE.
The comparison between the K58P-W60G and the
W60G mutant shows subtle yet interesting differences.
The K58P-W60G mutant displays fold stability, as
well as folding kinetics, comparable to the W60G
mutant [this work and (16)], and the two protein struc-
tures are virtually identical (0.34 A˚ r.m.s.d. over 99 Ca
pairs). The K58P-W60G and the W60G mutants dis-
play very similar propensities towards amyloid aggre-
gation. However, an unexpected difference is that
while theW60Gmutant, as all other b2m variants char-
acterized to date, shows a completely oxidized (intact)
Cys25Cys80 disulphide, the puriﬁed K58P-W60G
mutant is a mixture of oxidized (70%) and reduced
(30%) molecules, the latter lacking the stabilizing ef-
fects of the disulphide. Notably, in the K58P-W60G
mutant crystal structure the disulphide bond is fully
severed. Considering that no structural changes
appear to affect the protein backbone of the mutant,
thus its protein packing capability in the crystal lattice,
likely both oxidized and reduced forms coexist in the
crystals, even before exposure to X-rays. Complete
rupture of the disulphide bond is an effect of radiation
damage that is particularly visible in the case of the
K58P-W60G mutant. Indeed ESIMS analysis,
DTNB titrations and protein unfolding monitored by
Trp-ﬂuorescence (Fig. 4 and Supplementary Fig. S1)
show that a sizeable fraction of the puriﬁed protein is
reduced, lacking an intact disulphide bond. Such an
observation would be in keeping with a peculiar be-
haviour occasionally observed at the end of the mutant
protein puriﬁcation, whereby the puriﬁed K58P-W60G
mutant formed an ensemble of SDS-resistant oligo-
mers, which may correspond to covalent association
of b2m molecules through intermolecular disulphide
bonds (Supplementary Fig. S2B).
Fig. 5 Kinetics of ﬁbril formation for wt b2m and for K58P-W60G
mutant, at pH 7.4 and pH 2.5, monitored by ﬂuorescence using ThT
binding assay.Wt b2m and K58P-W60G were incubated at 37C and
diluted to 100mM concentration in a buffer containing 50mM Na
phosphate and 100mM NaCl, pH 7.4 in the presence of 20% TFE
(v/v) and 2.5 mg/ml wt b2m ﬁbril seeds. wt b2m and K58P-W60G
were incubated at 37C and diluted to a ﬁnal 100mM concentration
in a buffer containing Nacitrate 50 and 100mM NaCl, pH 2.5 in
the presence of 2.5 mg/ml wt b2m ﬁbril seeds.
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In our laboratory all b2m mutants are puriﬁed under
denaturing conditions and subsequently refolded ac-
cording to a standard protocol (8). After the refolding
step, ion exchange chromatography is used to separate
the protein population endowed with the correct sur-
face charges (i.e. properly folded). It is also known that
the disulphide bond is crucial for b2m to achieve a
correct fold, and is formed in the fast-phase of the
folding. Indeed, in our hands all the previously puriﬁed
b2m variants displayed an oxidized disulphide, sug-
gesting that the disulphide-reduced molecules either
fail the refolding step or are discarded through the
ion exchange chromatography step. Interestingly,
while all b2m variants show some precipitate during
the folding procedure (often the amount of precipitate
relates to the variant stability), upon refolding of the
K58P-W60G mutant almost no precipitate has been
observed, suggesting that the K58P-W60G mutant
may have a remarkable folding efﬁciency and that
the disulphide-reduced form that achieves a proper
fold can efﬁciently mimic the native oxidized variant.
The disulphide-reduced K58P-W60G b2m mutant
molecules are soluble and stable in solution, can crys-
tallize, and do not display higher aggregation forms in
size exclusion chromatography (data not shown). Such
a novel behaviour may be related to stabilization
encoded by the DE loop mutations, being speciﬁc for
the K58P-W60G mutant and distinct from the W60G
mutant, where disulphide-reduced properly folded
molecules have not been observed.
Previously characterized b2m mutants show that
modifying the DE loop backbone geometry deeply af-
fects b2m stability and amyloid propensity (1619).
The evidences here reported additionally stress the
structural role of the DE loop in b2m folding and sta-
bility; particularly, in the case of the K58P-W60G
double mutation, the DE loop properties appear to
affect not only fold stability but also the folding path-
way. In apparent contrast with what has been reported
for wt b2m, in the K58P-W60G mutant the disulphide
bond is not as crucial for b2m folding, and the
DE loop can promote folding independently of the
disulphide bond redox state.
Supplementary Data
Supplementary Data are available at JB Online.
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